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Bacterial diseases cause dysfunction, pain and even death in pigs of all ages. The use 
of antimicrobial agents is one of the most cost-effective tools in the efficient 
production of pork by reducing the distress and speeding the recovery in infected 
animals (Friendship, 2000). Antimicrobials are widely used in swine especially during 
treatment of respiratory and enteric diseases (De Briyne et al., 2014). In addition to 
treatment of sick animals, antimicrobials are used for control and prevention in 
healthy animals, specifically when periodic outbreaks of bacterial infections happen 
and the probability that most animals become infected is high (Barton, 2014). 
However, the recent emergence of antibiotic resistant bacteria in humans is putting 
into question the antibiotic practices in food animals.  (Aarestrup et al., 2008; 
Wallinga and Bursch, 2013; Anonymous, 2015). Therefore, there is a need to promote 
responsible use of antimicrobials in swine.  
 
Glasser’s disease is an important source of economic losses in current swine 
production systems. Glasser’s disease is caused by Haemophilus parasuis, a Gram-
negative bacterium that affects pigs, and is characterized by polyserositis, arthritis, 
meningitis, pneumonia and sudden death. H. parasuis also colonizes the upper 
respiratory tract (URT) of healthy pigs and colonization may be an important event in 
the development of immunity. For instance, inoculation of young piglets with 
pathogenic H. parasuis has been shown to reduce nursery mortality (Oliveira et al., 
2001a; 2003a). It was hypothesized that a protective immune response to H. parasuis 
was activated when pathogenic H. parasuis strains colonize the URT of pigs (Pijoan 
et al., 1997). Therefore, factors that can disrupt H. parasuis colonization, such as 
antimicrobial treatment, could affect the pig’s ability to develop a protective immune 
response against Glasser’s disease. 
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Antimicrobials have been widely used to treat and control Glasser’s disease (Aragon 
et al., 2012). Antimicrobials have also been shown to reduce H. parasuis colonization 
in weaned pigs (Vilalta et al., 2012) and anecdotal field observations suggest that 
mass treatment with antibiotics in pigs at weaning may render them more susceptible 
to Glasser’s disease later on. One hypothesis that would explain this observation is 
that early elimination (or lack of colonization) of H. parasuis may interfere with the 
development of immune responses. This mechanism has been previously 
demonstrated for other pathogens (North, et al., 1981; Su et al., 1999; Griffin et al., 
2009; Sjolund et al., 1009). Therefore, evaluating the impact of antimicrobial 
treatment on immune responses to H. parasuis should enable us to develop better 
treatment programs that will prevent reinfections. Towards this end, the goal of this 
PhD dissertation is to investigate the influence of antimicrobial treatment on H. 
parasuis colonization and infection, and its effect on the development of immune 
responses against H. parasuis in swine. The central hypothesis of this Ph.D. 
dissertation is that antimicrobial interfere with H. parasuis colonization and infection 
and, as a result, they affect the protective immune responses against Glasser’s disease. 
 
Little is known about how the pig immune system responds to H. parasuis 
colonization and infection. A serological test is needed to study the immune response 
to H. parasuis. However, most attempts to measure pig immune responses to H. 
parasuis used whole cell-based serological assays to measure serum IgG responses 
(Martin de la Fuente et al., 2009a; Cerda-Cuellar et al., 2010). Such serological 
methods lack sensitivity (do not detect responses against all H. parasuis strains) and 
specificity (may cross-react with responses against other Gram-negative bacteria). 
Therefore, a consistent and accurate serological test to characterize the development 
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of specific antibodies against H. parasuis in pigs is lacking. The first research chapter 
(chapter 2) describes the identification of a novel immunogenic and species-specific 
protein in H. parasuis, the oligopeptide permease A (OppA) protein. OppA is a 
transmembrane protein in Gram-negative bacteria responsible for capturing substrates 
from the environment (Monet, 2003). In chapter 2, the OppA protein is used to 
develop a serological test that detects antibodies against a wide range of H. parasuis 
strains. OppA immunogenicity was evidenced by the fact that only convalescent pigs 
or pigs vaccinated with recombinant OppA (rOppA) developed antibodies specifically 
against it.  
 
Another tool that is needed to study the complex relationship between H. parasuis 
infection, immune response and antibiotics is an experimental model for H. parasuis 
colonization. URT colonization by H. parasuis is considered a first step for H. 
parasuis infection. Numerous experimental inoculation models have been described 
for H. parasuis. However, those models were mainly designed to reproduce Glasser’s 
disease, and not H. parasuis colonization. In addition, they used colostrum deprived 
pigs, which do not fully represent the conventional pig in terms of the immune 
response they develop or the interactions that exist with the nasal microbiota. 
Therefore, there is a need for an infection model that simulates an asymptomatic 
colonization of the URT of pigs by pathogenic H. parasuis strains. In chapter 3, an 
experimental model that mimics nasal colonization in conventional pigs is proposed. 
We document that conventional pigs naturally carrying H. parasuis in their noses can 
be experimentally colonized by a pathogenic H. parasuis strain without developing 
Glasser’s disease. Absence of disease was evidenced by absence of clinical signs, and 
lesions, and lack of H. parasuis isolation and H. parasuis DNA detection in blood and 
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systemic tissues. The development of a pig model that mimics upper respiratory tract 
colonization in conventional pigs is a valuable tool to study H. parasuis colonization 
and infection. 
 
Alterations of H. parasuis URT colonization at a young age have been associated with 
occurrence of Glasser’s disease. Antimicrobials are commonly used to treat 
respiratory diseases in pigs. Specifically, enrofloxacin is used to control Glasser’s 
disease at weaning, a time when pigs are being exposed to different H. parasuis 
strains. We hypothesize that the administration of enrofloxacin can interfere with the 
colonization of the URT with H. parasuis. However, there is no information on the 
effect of enrofloxacin on H. parasuis colonization. Chapter 4 documents the reduction 
of both, the number of pigs positive to H. parasuis and the levels of H. parasuis in 
tonsils and nasal cavity of conventional pigs during the first week after treatment with 
enrofloxacin.  
  
Antimicrobials help the immune system to fight off disease by rapidly reducing or 
eliminating the bacterial challenge. However, early antimicrobial treatment can also 
interfere with the ability to mount an effective immune response by eliminating the 
pathogen before the immune system is activated. Chapter 5 describes the pig immune 
responses to pathogenic H. parasuis when pigs are treated with enrofloxacin before or 
after H. parasuis inoculation, and evaluates subsequent effects on protection against 
reinfection. Increase of serum IgG antibodies was observed after H. parasuis 
inoculation only when pigs were treated with enrofloxacin before inoculation and not 
when pigs were treated after inoculation. Such seroconversion was associated with 
protection against reinfection, and the effect of antibiotic treatment on the 
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development of such protection depended on the timing of infection and antibiotic 
administration.    
 
The final chapter (chapter 6) of this dissertation summarizes the findings and 
conclusions of this thesis, discusses limitations of the studies, and addresses future 
research needs. 
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1.1  Haemophilus parasuis  
Haemophilus parasuis is a Gram-negative bacterium member of the family 
Pasteurellaceae. Bacteria from the family Pasteurellaceae infect humans and a broad 
range of animals, often with marked host specificity, and are the cause of various 
diseases with different pathological features. The family Pasteurellaceae includes the 
genera Haemophilus, Pasteurella, and Actinobacillus, with pathogenic and 
commensal bacteria among them (Nicolet, 1990).  Moller and Kilian (1990) 
performed a systematic examination of the variety and ecology of members of the 
family Pasteurellaceae in the porcine upper respiratory tract (URT) demonstrating 
that healthy pigs of all ages harbor a wide spectrum of Pasteurellaceae species in 
their URT. 
 
H. parasuis is one of the most important disease causing bacteria affecting pigs. H. 
parasuis causes the syndrome known as Glasser's Disease, which is characterized by 
polyserositis and arthritis. H. parasuis is considered to be present in all major swine-
rearing countries and remains a significant disease in modern production systems. In 
the USA Glasser's disease is considered one of the main infectious problems in the 
nursery, but it can also affect growing pigs and sows (Aragon et al., 2012).  
 
Several models and routes of infection have been tested to study virulence, 
pathogenesis and immunity to H. parasuis (Morozumi et al., 1981, 1982; Nielsen, 
1993; Amano et al., 1994; Vahle et al., 1995; Oliveira et al., 2003a). Porcine 
polyserositis and arthritis due to H. parasuis infection are typically observed after 
weaning in affected herds (Oliveira et al., 2002). The clinical syndrome is typically 
acute with anorexia, nervous signs, and lameness with one or more joints affected. 
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Pigs often develop fever. Pigs that survive the acute disease have rough hair coats, 
poor weight gain and chronic lameness (Menard and Moore, 1990). Macroscopic 
lesions at necropsy reveal variable amounts of fibrinous to fibrinopurulent exudate 
present on multiple serosal surfaces including pleura, pericardium and peritoneum. 
Joints and meninges can also be affected with purulent arthritis and meningitis, 
respectively (Menard and Moore, 1990; Amano et al., 1994). Microscopically, these 
inflammatory lesions consist of deposition and infiltration of fibrin, neutrophils and 
occasionally macrophages (Hoefling, 1991; Vahle et al., 1995). Less commonly, H. 
parasuis infection can cause acute septicemia in which cyanosis, sub-cutaneous and 
pulmonary edema, and acute death can occur without the typical serosal inflammation 
(Peet et al., 1983). In the field, factors believed to be involved in Glasser's disease 
occurrence are stress related conditions, co-infection with viral pathogens, levels of 
maternal immunity, strain variability and differences in virulence (Aragon et al., 
2012). 
 
The existence of 15 distinct serovars was described by Kielstein and Rapp-Gabrielson 
(1992). They also demonstrated differences in virulence among the serovars after 
intraperitoneal inoculation of specific-pathogen-free (SPF) pigs. Studies also revealed 
the existence of high genetic heterogeneity among H. parasuis isolates, including 
genetic differences within serovar groups and among nontypeable isolates (Oliveira et 
al., 2003b; Olvera et al., 2006). Several studies indicate that H. parasuis strains differ 
in their ability to cause systemic disease in swine (Oliveira et al., 2003b; Olvera et al., 
2006). Recently, the complete genome of a virulent Chinese H. parasuis isolate was 
sequenced (Yue et al., 2009).  The genome size was about 2.3 Mb in a single circular 
chromosome composed of 2,292 predicted coding sequences. Several putative 
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virulence-associated genes were detected in the genome sequenced. Identification of 
novel putative H. parasuis virulence factors and mechanisms of virulence has been an 
active area of investigation (Zhou et al., 2009; Hong et al., 2011; Yuan et al., 2011; Fu 
et al., 2013). Some of the traditional virulence factors described for H. parasuis 
include fimbriae (Munch et al., 1992), capsule (Morozumi and Nicolet, 1986a), and 
lipooligosaccharide (LOS) (Biberstein, 1990).  
 
Fimbriation has been described for H. parasuis, and fimbriae may play a role in the 
colonization of the porcine URT (Munch et al., 1992).  H. parasuis colonizes the 
nasopharyngeal mucosal epithelium of pigs by attaching to the mucosal surface 
(Vahle et al., 1997). H. parasuis has also been consistently isolated from nasal cavity, 
tonsil, and trachea of pigs experimentally inoculated (Amano et al., 1994; Segales et 
al., 1997; Vahle et al., 1997; Kirkwood et al., 2001). For H. parasuis, the expression 
of fimbriae is dependent on cultivation and growth conditions. Fimbriae could not be 
identified when H. parasuis was grown using conventional cultivation methods, but 
rather when it was in contact with living tissue. Embryonated hen eggs have been 
used as a model to reproduce in vivo conditions. H. parasuis grown under these 
conditions have filamentous structures on the surface, which have been identified as 
fimbriae by electronic microscopy (Munch et al., 1992). However, the role of fimbriae 
for adhesion and as a virulence factor for H. parasuis needs to be clarified. 
 
The presence of polysaccharide capsule is recognized as an important virulence 
attribute in preventing phagocytosis and bactericidal serum activity by complement. 
Encapsulated strains are potentially more virulent. However, the presence of capsule 
does not always correlate with virulence (Sandal et al., 2010). The presence of a 
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polysaccharide capsule on H. parasuis has been confirmed (Morozumi and Nicolet, 
1986a), but it has not been purified or chemically characterized. Encapsulated and 
non-capsulated H. parasuis clones can be induced by in vivo or in vitro passages, 
respectively (Oliveira and Pijoan, 2002). Most of H. parasuis isolates from the upper 
respiratory tract of healthy pigs have been found to be encapsulated, whereas the 
majority of isolates from systemic sites of diseased pigs have been non-capsulated 
(Morozumi and Nicolet, 1986a). Different results were observed by Olvera et al. 
(2009), where H. parasuis strains isolated from polyserositis lesions had a prominent 
capsule and resisted phagocytosis, while capsule was not detected in strains isolated 
from the nose of healthy pigs. Therefore, the association of capsule with virulence is 
still controversial. 
 
Lipopolysaccharide (LPS) is a prominent surface component of all Gram-negative 
bacteria. The term lipooligosaccharide (LOS) has become standard when referring to 
the LPS of bacteria from the genus Haemophilus because they lack polymerized O-
antigen side chains (Sandal et al., 2010). Zucker et al. (1996) examined LOS 
production by H. parasuis, and found that virulent and avirulent strains shared similar 
patterns, which suggests that LOS might not be a good indicator of virulence. 
 
Outer membrane proteins (OMPs) have been associated with virulence among H. 
parasuis strains. Potentially pathogenic H. parasuis isolates analyzed by 
polyacrylamide gel electrophoresis (PAGE) shared a 37 kDa major protein and were 
classified as PAGE type II, whereas isolates lacking this protein were classified as 
PAGE type I (Morozumi and Nicolet, 1986b; Ruiz et al., 2001).  Pigs that survive H. 
parasuis challenge developed antibodies to OMPs but not to capsule or LOS, which 
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may suggest that antibodies against OMPs could be related to protection (Miniats et 
al., 1991). However, the role of H. parasuis OMPs as virulence factors or 
immunogens remains to be defined. 
 
Hitherto, vaccination and antibiotics are the standard methods to prevent and control 
H. parasuis outbreaks. Seronegative pigs of all ages are extremely susceptible to 
Glasser's disease (Riising, 1981). Pigs acquire protective immunity against H. 
parasuis after recovery from systemic infection (Riising, 1981; Smart and Miniats, 
1989; Miniats et al., 1991; Solano-Aguilar et al., 1999; Cerda-Cuellar et al., 2010). 
Moreover, there are numerous reports of successful control by vaccination with 
commercial or herd-specific (autogenous) bacterins (Smart and Miniats, 1989; 
Miniats et al., 1991; Kirkwood et al., 2001; Takahashi et al., 2001). There are also 
instances where bacterins are not efficacious. Lack of vaccine efficacy may be due to 
lack of cross-protection for the strain or serovar involved in the disease process or to 
inappropriate vaccination timing (Miniats et al., 1991; Rapp-Gabrielson et al., 1997). 
 
Additionally, when vaccinating piglets against H. parasuis, it is important to consider 
interference of maternal antibodies with the development of active immunity by 
vaccinated pigs (Bak and Riising, 2002). Solano-Aguilar et al. (1999) demonstrated 
that vaccinated piglets born to vaccinated gilts were not affected by Glasser's disease 
after challenge with H. parasuis, while vaccinated pigs born to non-vaccinated gilts 
developed severe polyserositis. Additionally, Cerda-Cuellar et al. (2010) showed that 
maternal antibodies could help explain the absence of H. parasuis disease during the 
first weeks of life, even though most of the pigs are colonized shortly after birth. 
Vaccination of sows resulted in higher IgG levels in serum of pigs, with consequent 
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delay of H. parasuis colonization and reduction of heterogeneity of strains, compared 
with pigs born to non-vaccinated sows (Cerda-Cuellar et al., 2010). 
 
According to Robinson (2004), colonization implies that the patient has a sufficiently 
high concentration of organisms at the site that they can be detected, without causing 
any clinical signs or symptoms. Colonization can persist for days to years, with 
resolution influenced by the immune response to the organism, competition at the site 
from other organisms and, sometimes, use of antimicrobials. The most important 
factor in determining if a patient is colonized or infected with an organism is the 
clinical presentation (Robinson et al., 2004). Smart et al. (1988, 1989) found that pigs 
from SPF herds could carry H. parasuis in the nose. However, Glasser's disease only 
affected SPF animals when they were mixed with apparently healthy conventional 
pigs carrying distinct H. parasuis strains. Introduction of H. parasuis into non-
immune populations may result in high morbidity and mortality with spread of 
infection to swine of all ages without necessarily being associated with stress factors 
(Riising 1981). Vahle et al. (1995) reported that H. parasuis colonizes the nasal cavity 
as an initial event in the pathogenesis of H. parasuis infection of cesarean-derived 
colostrum-deprived (CDCD) swine. Nasal discharge and rhinitis after H. parasuis 
inoculation was followed by lesions of polyserositis and recover of the bacterium 
from nasal mucosa and systemic sites. Therefore, to determine the significance of H. 
parasuis isolates, one must consider the site of isolation and, most importantly, the 
clinical picture.  
 
 Controlled exposure has been adopted by some herds as an alternative method to 
control H. parasuis in the nursery. This method consist of identifying the prevalent H. 
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parasuis strains causing disease in a farm and exposing 3 to 5-day old piglets to a low 
dose of these live pathogenic strains. Field studies have demonstrated that this method 
may reduce nursery mortality by 50% (Oliveira et al., 2001a). The mechanism behind 
such protection was not determined but it was hypothesized that controlled exposure 
results in H. parasuis colonization and, in the presence of maternal immunity, may 
elicit a protective immune response without causing disease (Pijoan et al., 1997). This 
method was also effective at reducing nursery mortality compared to vaccination 
(Oliveira et al., 2004).   
 
Appropriate use of antibiotics is considered an important component of Glasser’s 
disease management either to treat disease or prevent it (Desrosiers et al., 1986). Pigs 
receiving antibiotic treatment early during infection with H. parasuis are usually able 
to survive systemic infection with this bacterium. Most H. parasuis strains are 
sensitive in vitro to antibiotics used in the swine industry (Aarestrup et al., 2004). The 
main antimicrobial agents used to treat swine respiratory infections include 
trimethoprim-sulfa, tetracycline, penicillin, ceftiofur, tulathromycin, ampicillin, 
lincomycin, tylosin, tiamulin and enrofloxacin. However, therapeutic options 
approved to treat H. parasuis are limited to enrofloxacin, ceftiofur, penicillin and 
tulathromycin (Papich and Riviere, 2009). Oral antibiotics have also been 
recommended as a preventive medication program for herds in which H. parasuis is a 
problem. Antibiotics may be effective at controlling H. parasuis infection by reducing 
morbidity and mortality, and improving clinical scores and growth parameters in 
treated pigs.  
 
1.2 Protective Immunity 
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There has been a great expansion on knowledge in regards to the pig immune system 
and its effect in disease and vaccination. Immune response starts when 
microorganisms enter the host and engage the immune system. The innate immune 
system is the first line of defense, typically activated shortly after infection. Pattern-
recognition receptors (PRRs), including the toll-like receptors (TLRs), monitor 
pathogen-associated molecular patterns (PAMPs) and induce different signaling 
pathways to activate the immune system against infection. The phagocytic cells of the 
innate immune system and production of various cytokines provide antimicrobial 
protection, recruit cells through the inflammatory process and assist in the activation 
of acquired immunity. The acquired immune response activation results in cytokine 
production, T-cell and B-cell activation, and antibody production. The acquired 
immune response also provides pathogen-specific memory for protection against 
subsequent infections with the same pathogen (Chase and Lunney, 2012). 
 
Most information present in the literature describes the antibody-mediated immune 
response to H. parasuis (Riising, 1981; Miniats et al., 1991; Nielsen, 1993; Rapp-
Gabrielson et al., 1997, Solano-Aguilar et al., 1999; Martin de la Fuente et al., 2009a), 
whereas little information is available for cell-mediated responses (Martin de la 
Fuente et al., 2009b; Frandoloso et al., 2012a).  
 
1.2.1 Innate Defense Mechanisms 
Innate immunity may be sufficient to protect a host against an invading agent or to 
prevent disease from occurring since it does not require previous exposure to antigen 
(Kindt et al., 2007). Innate immunity enables the pig to respond almost immediately 
to an infectious agent, controlling infection until activation of the adaptive immune 
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system (Roth, 2005). Intact skin and mucous membranes participate in the innate 
immune response by providing physical barriers to infection. The anatomical defenses 
are also associated with chemical barriers (lysozyme) and commensal microbiota that 
prevents colonization of body surfaces by pathogenic bacteria (Roth, 2005).  
PRRs are a key component of the innate immune system. PRRs are receptors present 
in mammalian cells that are able to distinguish between PAMPs, which are conserved 
molecules present on microorganisms, such as LPS and peptidoglycans, and harmless 
antigens. TLRs are an example of these molecules (Uenishi and Shinkai, 2009). TLRs 
are present on cells belonging to the innate immune system, such as macrophages, 
neutrophils and dendritic cells. Innate immune responses are initiated by the contact 
between bacterial PAMPs and host TLRs followed by activation of NfκB signaling 
pathway. This activation leads to the activation of a transcription factor that turns on 
cytokine genes such as those for tumor necrosis factor-alpha (TNF-α), IL-1, and 
chemotactic attractants. The subsequent inflammatory response helps to activate other 
aspects of innate immunity and to initiate the acquired immune response (Akira and 
Hemmi, 2003).  
 
Bacterial invasion will also be challenged by the activation of complement in blood 
and tissues and the stimulation of an inflammatory process that attracts both the innate 
and adaptive immune defenses to the site of invasion (Kindt et al., 2007; Ryan and 
Ray, 2010). The complement system participates in several innate immune reactions 
such as inflammation, phagocytosis and bacterial killing; however, it is also capable 
of causing serious damage to the host, if it is activated in an unregulated fashion. 
Complement is an enzymatic system composed of at least 20 serum proteins that are 
sequentially activated through one of two pathways, the classical and the alternative 
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pathways, involving the membrane attack complex and regulatory proteins. The 
classical pathway is activated by antigen-antibody complexes consisting of 
immunoglobulins IgG and IgM. The reaction between immunoglobulins and antigen 
activates the complement and initiates a cascade reaction on the surface of the 
microbe. The result of this reaction is the formation of pores in the cell wall that will 
lead to bacterial death. The alternative pathway of complement activation is mediated 
by certain bacterial products such as endotoxins (including bacterial LPS, 
peptidoglycan and teichoic acids). This allows antibody-independent activation of the 
complement cascade that is considered important in initial (pre-antibody) defense 
against various types of infections caused by bacteria (Kindt et al., 2007). Activation 
of any of the complement pathways cause vasodilatation and increased vascular 
permeability resulting in serum components (including antibodies and complement) 
entering the tissues to help control infection. Complement components produced 
during activation are chemotactic and attract phagocytic cells to the site of infection. 
They also coat or opsonize infectious agents to increase their uptake by phagocytic 
cells. Complement components also destroy pig cell membranes and some bacterial 
cell membranes (Chase and Lunney, 2012). Therefore, the complement system is 
important for mediating inflammation and controlling bacterial infections. 
 
Little information is currently available for innate immune response to H. parasuis. 
Immunohistochemistry and in situ hybridization methods have demonstrated that 
following infection, H. parasuis is phagocytosed by neutrophils and macrophages and 
can be found as degenerated bacteria in dilated phagosomes (Amano et al., 1994; 
Segales et al., 1997). Moreover, a recent study showed that H. parasuis susceptibility 
to phagocytosis by porcine alveolar macrophages (PAMs) correlates with the clinical 
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origin of the strain (Olvera et al., 2009). H. parasuis strains isolated from systemic 
lesions (virulent) were resistant to phagocytosis, while nasal strains (non-virulent) 
were efficiently phagocytosed by PAMs in vitro, followed by subsequent bacterial 
death within the macrophage. Phagocytosis resistance by H. parasuis virulent strains 
is likely associated with presence of capsule (Olvera et al., 2009), which can interfere 
with complement deposition (Sandal et al., 2010).  
 
Also playing an important regulatory role in modulating the immune responses, 
cytokines are proteins and glycoproteins that are secreted by cells and serve as 
intercellular signaling molecules. All cells of the immune system are capable of 
secreting and being influenced by cytokines. Cytokine secretion is usually transient, 
occurs in response to specific stimuli, and typically cytokines act locally in low 
concentrations. A cytokine will only act in a cell that has specific receptors for it. 
Regulation of cytokine receptor expression is an important mechanism for controlling 
the response to cytokines (Kindt et al., 2007). Most porcine cytokines that have been 
studied are similar to their orthologs in humans or mice (Chase and Lunney, 2012). 
Some cytokines are important in mediating innate immunity. This includes the type I 
interferons (IFN-α/β) and the pro-inflammatory cytokines that include IL-1, IL-6, and 
TNF-α. Type I IFN production occurs in response to viral infection by many cell 
types. Type I IFN make cells resistant to viral infection, increase natural killer cell 
(NK) activity, and increase major histocompatibility complex (MHC) molecule 
expression on cell surfaces, thus increasing antigen presentation to T cells (Roth, 
2005). The proinflammatory cytokines (IL-1, IL-6, and TNF-α) are produced 
primarily by macrophages in response to bacterial infection and require no previous 
exposure. They may also be produced in response to viral, protozoal, fungal 
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infections, or tissue damage. The proinflammatory cytokines stimulate the liver to 
produce acute-phase proteins. In addition, they induce fever, loss of appetite, and 
fatigue if present in high enough concentrations (Roth et al, 1997; Murtaugh and Foss, 
2002; Chase and Lunney, 2012).  
 
While the presence of cytokines is required for effective stimulation of immune 
responses, in large quantities they can induce hypovolemic shock and death (Kindt et 
al., 2007). Therefore, the adequate modulation of cytokine production is essential for 
control and elimination of bacterial infections. An infection model was created to 
study the expression of inflammatory cytokines during acute respiratory disease 
caused by A. pleuropneumoniae in swine. IL-1, IL-8, TNF and IL-6 mRNA were 
detected within 2 to 4 hours after bacterial infection by in situ hybridization and 
Northern blotting in all inoculated pigs (Baarsch et al., 1995; 2000). IL-1 might 
contribute to increased severity of disease, but elevated IL-6 levels were consistent 
with a protective acute phase response. The low TNF levels observed in this study 
were surprising, since TNF was hypothesized to be triggering the inflammatory 
cascade (Murtaugh et al., 1996). Another study demonstrated that macrophage 
activation involving high production of IL-1 and TNF was associated with severe lung 
injury in cases of A. pleuropneumoniae infection (Morrison et al., 2000). Increase of 
pro-inflammatory cytokines after infection with A. pleuropneumoniae indicated that 
cytokines were associated with the development of pleuropneumonia disease and 
contributed to disease injury (Morrison et al., 2000).  
 
Similarly, H. parasuis was able to stimulate the production of proinflammatory 
cytokines IL-8 and IL-6 by pig tracheal cells and endothelial cells in an in vitro model 
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(Bouchet et al., 2008; 2009; Aragon et al., 2010). Acute phase response stimulated by 
IL-6 production and chemoattraction of leucocytes stimulated by IL-8 represent 
essential roles of these cytokines in inflammatory response to H. parasuis. Increased 
IL-1α expression in lung has been reported in pigs undergoing severe disease 
following experimental infection, whereas IL-4, IL-10, tumor necrosis factor-alpha 
(TNF-α), and (IFN-γ) were expressed in significantly higher levels in spleen, 
pharyngeal lymph nodes, lung and brain of survivors, which suggests that these 
cytokines might contribute to protection against H. parasuis (Martin de la Fuente et 
al., 2009c). 
 
1.2.2 Acquired Immunity  
While the porcine innate immune system confers initial protection, the acquired 
immune system provides a second, more specific and long lasting, line of defense 
against infectious organisms (Lunney, 2005). In non-immune animals, precursor T 
cells exist as "resting T cells", bearing T-cell receptors (TCRs) for specific antigens. 
Various innate signals, such as TLR signaling and cytokines, attract immune cells to 
the local tissues where they undergo activation. These immune cells then use their 
surface molecules to signal each other's activation (Lunney, 2005). Foreign antigens 
must be processed by antigen presenting cells (APCs) to stimulate adaptive immunity. 
The induction of clonal expansion of the immune response requires complex 
interactions of macrophages, T, and B-lymphocytes (Kindt et al., 2007). 
 
Following antigen stimulation, CD4+ T cells differentiate into T helper (Th) cells 
with a characteristic cytokine secretion profile. The mice Th-1 patterns of cytokine 
production include IL-2 and IFN-γ, whereas Th-2 cells produce IL-4, IL-5, IL-6, IL-9, 
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IL-10 and IL-13. Some cytokines are secreted by both Th-1 and Th-2, including IL-3, 
TNF-α and granulocyte-macrophage colony-stimulating factor (GM-CSF) (Mosmann 
and Sad, 1996). The functions of Th-1 and Th-2 cells correlate with the production of 
their cytokines. Th-1 cytokines are involved in cell-mediated inflammatory functions, 
while Th-2 cytokines encourage antibody production, and also enhance eosinophil 
proliferation and function (Mosmann and Sad, 1996). 
 
The number of studies conducted on porcine cellular immune responses to infectious 
microorganisms has increased in recent years, but it is still limited, in comparison 
with work performed on other species. Specific reagents, improved technology and a 
more detailed knowledge of the porcine immune cell populations now enables better 
association of the interactions between pathogens and the porcine immune system, 
and detailed analyses of the antigen-specific T-cell response (Saalmuller, 1998). 
Although protective immunity against extracellular bacteria is mainly dependent on 
antibodies, T cell responses are often required for full expression of immunity (Chase 
and Lunney, 2012).   
 
In order to stimulate the adaptive immune response, the foreign antigen must be 
processed by an APC. APCs internalize bacterial agents and then present antigenic 
fragments bound to MHC II molecules on the surface of the cell.  This antigen-MHC 
II complex is presented to a Th-2 cell, which can only efficiently recognize foreign 
antigens that are on the cell surface bound to MHC class II molecules. In addition to 
antigen-MHC II complex, the Th cell requires the presence of cytokines released by 
APCs and other T cells, and contact with co-stimulatory molecules on the surface of 
the APC for complete activation. Following antigen presentation, the macrophage will 
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secrete IL-1, which will activate Th-2 cells to secrete IL-2. IL-2 will induce Th-2 cells 
to proliferate. This process continues with stimulated Th-2 cells secreting a variety of 
other cytokines including IL-2, IL-4, IL-6, and IFN-γ. IL-4 causes B cells to 
proliferate and differentiate into antibody-secreting plasma cells and memory B cells 
(Lunney, 2005; Kindt et al., 2007; Chase, 2012). In pigs, however, IL-4 seems to play 
a different role than in mice. Porcine IL-4 was not able to stimulate porcine B cell and 
it blocked antibody production. Porcine IL-4 did have a stimulatory effect on 
lymphoblast's cell growth (Murtaugh et al., 2009). Therefore, the role of IL-4 in 
porcine immunology needs further investigation. Appleyard et al. (2002) evaluated 
possible correlates of protection in blood lymphocyte subset phenotypes of pigs 
receiving either a commercial A. pleuropneumoniae bacterin, low dose (LD) of 
aerosol infection with the same bacteria, or control group. All pigs were subsequently 
challenged with a high dose of A. pleuropneumoniae. B-cells increased following 
vaccination. CD4+ lymphocytes increased significantly in both vaccinated and LD 
groups after challenge, while CD8+ cells decreased in the LD-group (Appleyard et al., 
2002).  
 
Specific changes in peripheral blood mononuclear cells (PBMC) were found in 
colostrum-deprived pigs after challenge with virulent H. parasuis strain, but not after 
immunizations (Martin de la Fuente et al., 2009b; Frandoloso et al., 2012a). These 
changes consisted mainly of increase in the relative proportions of T and B-
lymphocytes in immunized pigs that survived challenge (Martin de la Fuente et al., 
2009; Frandoloso et al., 2012a). As extracellular pathogens, A. pleuropneumoniae and 
H. parasuis would be expected to require a dominantly Th-2 response to mediate host 
resistance. Several studies show that bactericidal antibody production appears to 
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correlate with protection (Ryan and Ray, 2010). Yet, the appearance of the different 
subsets of T lymphocytes during infection with these two bacteria might also be 
relevant to protection.  
 
Helper lymphocytes are also critical in initiating B-cell responses, which result in 
antibody production. B cells contact antigen through antibodies bound to their 
surface, which act as B-cell receptors (BCRs). Contrary to T-cells, B-cells can react 
with soluble antigens, without having to be presented on MHC class II molecules by 
APCs. However, optimal B-cell response to antigen requires Th-cell release of 
cytokines. When a B-cell is bound to antigen, and simultaneously is stimulated by IL-
4 produced by a nearby Th-2 cell, the B cell undergoes mitosis and clonal expansion. 
At the same time, B cells differentiate into plasma cells or memory cells and 
experience class switching of antibody production from IgM to IgG, IgA, or IgE. The 
antibodies secreted by plasma cells react specifically with the homologous antigen 
that induced their formation. Even though they produce large amounts of antibodies, 
plasma cells are relatively short-lived (about one week). Therefore, B-cells also 
differentiate into memory cells, which are relatively long-lived and upon subsequent 
exposure to antigen, they become quickly transformed into antibody-producing 
plasma cells (Kindt et al., 2007). 
 
Development of antibodies against H. parasuis has been demonstrated in 
convalescent and vaccinated pigs by complement fixation, western blot analysis, and 
ELISA testing (Miniats et al., 1991; Nielsen, 1993; Solano-Aguilar et al., 1999). Pigs 
exposed to H. parasuis live cultures or vaccinated with killed bacterins generate a 
transient immunoglobulin M (IgM) response followed by a solid and progressively 
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increasing IgG antibody response. Pigs with high titers are protected against challenge 
(Martin de la Fuente et al., 2009a), while Glasser's disease has been associated with 
absence or low titers of serum antibodies (Riising, 1981; Rapp-Gabrielson et al., 
1997). Moreover, passive immunization of pigs with serum containing specific 
antibodies against H. parasuis was demonstrated to have protective effects against 
lethal challenge (Nedbalcova et al., 2011). In vitro studies suggested that antibodies 
play an important role in opsonization of virulent H. parasuis strains to facilitate 
phagocytosis (Olvera al., 2009). Virulent H. parasuis strains required prior 
opsonization with specific antibodies in order to be phagocytosed by PAMs and, if 
internalized, they were killed by PAMs (Olvera et al., 2009).  
 
Maternal antibodies are a critical factor protecting pigs against the development of 
systemic infection and, apparently, there is no interference with the pig’s active 
immunity (Solano-Aguilar et al., 1999). Additionally, pigs lacking maternal immunity 
were susceptible to Glasser's disease upon inoculation with a virulent H. parasuis 
strain, whereas pigs that received maternal immunity were protected (Blanco et al., 
2004). Cerda-Cuellar et al. (2010) further demonstrated the importance of a good 
balance between colonization and immunity to avoid systemic disease caused by H. 
parasuis. Piglets from vaccinated sows had significantly higher levels of antibodies 
earlier after birth, and were colonized later and to a lower degree than piglets from 
non-vaccinated sows. The peak of H. parasuis nasal colonization for both groups was 
at 60 days of age, when H. parasuis was isolated from the nose of 100% of piglets 
from non-vaccinated sows and 85.7% of pigs from vaccinated sows. Furthermore, the 
increase in colonization rate was associated with a decrease in H. parasuis serum 
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antibodies in piglets, which indicates that the level of maternal antibodies in piglets 
might be able to modulate the timing and level of colonization by H. parasuis. 
 
Besides causing systemic disease, H. parasuis is also commonly isolated from the 
upper respiratory tract of healthy pigs. Consequently, H. parasuis might interact with 
the mucosal immune system, possibly resulting in priming of the immune response. 
Indeed, pigs exposed to aerosol containing live non-pathogenic H. parasuis cells 
developed serum antibodies and resisted challenge with virulent H. parasuis strains 
(Nielsen, 1993). Moreover, oral exposure of 5-day-old pigs to a low dose of a live H. 
parasuis strain significantly reduced mortality compared to vaccination (Oliveira et 
al., 2004).  
 
In addition to serum antibodies, secretory IgA (sIgA) serves as an important 
protective mucosal element. The B cells that produce IgA preferentially migrate to 
submucosal tissues where they differentiate into plasma cells that secrete IgA. SIgA 
antibodies bind to the poly-Ig receptor on the basolateral surface of respiratory 
epithelial cells, and are transported to the mucosal surface of the epithelial cell. The 
cleavage product is called the secretory component and remains bound to the dimeric 
IgA (Snoeck, et al., 2006). Contrary to serum IgA antibodies, sIgA is not able to 
trigger phagocytosis, which is presumably due to blockage of Fc part of the IgA 
heavy chain by the secretory component. However, sIgA antibodies contribute to the 
protection of the mucosal epithelial barrier through other mechanisms. SIgA 
antibodies help clear pathogens by preventing adherence of microorganisms to 
epithelial cells. Dimeric sIgA is still more efficient than IgA because it can cross-link 
large antigens with multiple epitopes. Complexes of sIgA and antigen are easily 
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entrapped in mucus and then eliminated by the ciliated epithelial cells (Snoeck, et al., 
2006).  
 
Little is known about the mucosal immune response to H. parasuis in the respiratory 
tract of pigs. Levels of IgA increased in nasal secretions and bronchoalveolar lavage 
(BAL) fluid from pigs vaccinated intranasally with a subunit vaccine containing 
recombinant virulence associated trimeric autotransporter (VtaA) and it was 
associated with partial protection against H. parasuis challenge (Olvera et al., 2011). 
In a different study, specific IgA against H. parasuis was detected in serum of pigs 
immunized with a subunit vaccine when the vaccine was delivered intratracheally, but 
not when it was delivered intramuscularly. However, the presence of IgA in the 
respiratory tract was not evaluated (Martinez-Martinez 2012).   
 
1.3 Effects of antimicrobials on the immune response 
Antimicrobials have been widely used in the swine industry since they were 
discovered over 50 years ago. The use of antimicrobial agents during all phases of 
pig's growth is one of the most cost-effective tools in the efficient production of pork. 
Increase in disease challenge due to the decline of small farms and increase in the 
larger ones, particularly in the USA, is associated with an increase of the use of 
antimicrobials in pork production (Friendship, 2000). The emergence and re-
emergence of viral diseases, particularly porcine reproductive and respiratory 
syndrome (PRRS) virus and porcine influenza virus which are often found interacting 
with bacterial agents has also been associated with an increased use of antimicrobials 
to control swine respiratory disease (VanAlstine, 2012).  
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Antimicrobials are mainly used in the swine industry for growth promotion, disease 
prevention and treatment (Cromwell, 2002). Antimicrobials in swine have also been 
used as part of disease elimination programs for pathogens such as Mycoplasma 
hyopneumoniae (Dee, 1994, Rautiainen et al., 2001) and A. pleuropneumoniae 
(Andersen and Gram, 2004). However, pathogen elimination has not always been 
successful, in particular for pathogens such as H. parasuis and Streptococcus suis, 
considered part of the commensal flora of the pig (Clark, 1994). The majority of 
antimicrobial drugs used in swine farms are incorporated into feed for growth 
promotion (subtherapeutic use) (Friendship, 2000).  
 
The present review will deal primarily with antimicrobial drugs as therapeutic agents. 
The in vivo response of a host and bacteria to an antimicrobial agent is a product of 
the interaction of many factors including susceptibility of the bacteria to the agent, 
age and immune status of the host, existing disorder, and route of antimicrobial 
administration (Ngwai et al., 2011). Therefore, selection of the adequate antimicrobial 
agent depends on the antimicrobial sensitivity pattern of the pathogenic organism, the 
established MICs of the antimicrobials being considered, the legislation concerning its 
use, and the drug's cost (Friendship, 2000).  
 
According to data from the National Animal Health Monitoring System (NAHMS) 
Swine 2006 study collected from 514 swine production sites, the most common 
antimicrobials given by injection to nursery-age pigs for disease treatment or 
prevention were ceftiofur and procaine penicillin G (43 and 43.9 percent of sites, 
respectively). About half of sites with nursery-age pigs (48.6 percent) used injectable 
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antimicrobial to treat respiratory disease and the most common actions taken for pigs 
with clinical respiratory disease were to administer antimicrobials to all pigs in the 
entire room with clinically ill pigs (39.6 percent of sites). Therefore, the use of 
antibiotics in swine is widespread, not only as growth promoters in the feed, but also 
to control and treat disease by intramuscular administration. While it is clear that the 
use of antimicrobials is an important tool to control disease in pigs, its potential effect 
on the immune response is less understood.   
 
1.3.1 Effect of antimicrobials on bacterial infection and immune response  
The widely known activity of antimicrobial agents is the direct (bacteriostatic or 
bactericidal) effect against microorganisms. Antimicrobials decrease the bacterial 
load and thereby permit the host to activate immune defenses and eliminate the 
pathogen without excessive inflammation (Walker, 2000; Labro, 2000). At the same 
time, early elimination of the pathogen by antibiotics may hinder the development of 
a protective immune response necessary to overcome future infections (Su et al., 
1999; Griffin et al., 2009). Additionally, antimicrobial use in swine may affect the 
commensal microbiota with unpredictable effects on disease dynamics (Macedo et al., 
2012; Vilalta et al., 2012).  
 
In regards to the effect that antimicrobials may have on the development of an 
immune response, early elimination of bacterial infection has been reported to have an 
effect on the immune response activation (North et al., 1981; Su et al., 1999; Griffin 
et al, 2009; Sjolund et al., 2009; Johanns et al, 2011). An undesirable effect of 
antimicrobial-induced elimination is the substantial reduction in the generation of 
immunologic cell-mediated memory. In the case of Listeria monocytogenes infection 
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in mice, when ampicillin was employed to rapidly eliminate infection at any time 
during the first 5 days post infection, there was a great reduction in the capacity of 
antibiotic-treated mice to resist a subsequent challenge. The earlier the primary 
infection was eliminated, the lower the level of immunologic memory generated. 
Additionally, when ampicillin was used to eliminate remaining bacteria at the time of 
peak response (day 6 after infection), the rate of decay of immunity, as measured by 
the rate of loss of protective T cells from the spleen, was greatly increased. Therefore, 
the magnitude and duration of the T cell-mediated anti-Listeria immune response 
were determined by the level and duration of infection with live, replicating antigen 
(North et al., 1981). 
 
Similarly, other studies have shown that early antibiotic treatment can prevent the 
development of protective immunity against reinfection with Chlamydia trachomatis 
and Salmonella sp. (Su et al., 1999; Griffin et al, 2009). Mice that can spontaneously 
resolve primary infection with C. trachomatis exhibit significant resistance to 
reinfection and that correlates with the production of local IgA and IgG, and with a 
chlamydial-specific CD4+ Th1 cell–mediated immune response (CMI) (Williams et 
al., 1997). In contrast, treatment with doxycycline at the time of infection (day 0) and 
at days 3, 7, and 10 post infection, resulted in a significant reduction in chlamydial-
specific antibody, CMI responses and protection against secondary chlamydial genital 
infection (Su et al., 1999).  
 
Antimicrobials used to eliminate primary Salmonella sp. infection also rendered mice 
susceptible to secondary infection against Salmonella sp. Protection from Salmonella 
sp. requires Salmonella-specific Th1 cells. The optimal development of that protective 
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immunity requires at least two weeks of exposure to the live attenuated Salmonella sp. 
strain (Griffin and MacSorley, 2011).Antibiotic treatment in the water with 
enrofloxacin for 5 weeks beginning 2 days post infection not only prevented the 
development of an effective immune response but also rendered the animals 
susceptible to challenge infection. Even though the specific immune response was 
activated rapidly in antibiotic-treated mice, it was not sustained after successful 
antibiotic treatment (Griffin et al., 2009). In contrast, a different murine model of 
persistent Salmonella infection demonstrated that water treatment with enrofloxacin 
starting as early as 5 days post infection eliminated primary infection without 
rendering mice susceptible to the secondary infection. Interestingly, in this case 
protection was not mediated by CD4+ or CD8+ T cells because depletion of these 
cells either alone or in combination prior to the second challenge did not abrogate 
protection. Instead, robust levels of Salmonella-specific antibody were primed and 
were shown to be protected when transferred to naïve mice (Johanns et al, 2011).  
 
One study has been performed on the effect of antibiotic treatment on the immune 
response in swine. In the case of A. pleuropneumoniae, Sjolund et al. (2009) 
investigated the susceptibility to an initial challenge and re-challenge with 
Actinobacillus pleuropneumoniae in SPF pigs that were treated with antimicrobials 
(penicillin, enrofloxacin or tetracycline) at the onset of clinical signs. After initial 
exposure to A. pleuropneumoniae, the inoculated control and the penicillin-treated 
groups developed severe disease, but the groups treated with enrofloxacin and 
tetracycline recovered rapidly. All the inoculated pigs, except those treated with 
enrofloxacin, developed serum antibodies to A. pleuropneumoniae, which protected 
them against the second challenge (Sjolund et al., 2009). Therefore, in this case the 
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development of a protective immune response was impeded by treatment with 
enrofloxacin but not by treatment with penicillin or tetracycline.  
 
There is no specific information available on the role of antibiotics on the immune 
response to H. parasuis.  However, fluoroquinolones have been associated with 
potential interference with the dynamics of respiratory colonization of bacterial 
pathogens including H. parasuis, in pigs (Le Carrou et al., 2006; Macedo et al., 2012; 
Vilalta et al., 2012). Fluoroquinolones are used to treat respiratory diseases (Papich 
and Riviere, 2009). These drugs are known for their high efficiency and very low 
levels of resistance. In the case of H. parasuis, intramuscular administration of 
marbofloxacin was able to reduce the nasal carriage of H. parasuis in weaned pigs 
(Vilalta et al., 2012). In another study, enrofloxacin reduced the numbers of H. 
parasuis in the tonsil and nasal cavity of pigs and decreased the number of positive 
pigs during the first week after treatment (Macedo et al., 2012). Both, marbofloxacin 
and enrofloxacin, showed a similar effectiveness after treatment, being able to reduce 
the amount of H. parasuis in the upper respiratory tract of pigs but not to eliminate it. 
As mentioned in a previous section of this manuscript, reduction in H. parasuis 
colonization at a young age has been associated with the development of Glasser’s 
disease during the post-weaning period (Pijoan et al., 1997, 2003; Oliveira et al., 
2001a, 2004). Therefore, antibiotic treatments that interfere with H. parasuis 
colonization in young pigs could result in increased disease susceptibility at an older 
age. However, no studies have been performed on this topic.    
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1.3.2 Antimicrobial Immunomodulation 
In addition, some antimicrobials can directly modulate innate and adaptive immune 
responses. Antimicrobial agents such as beta-lactams, quinolones, and macrolides, are 
commonly used in the treatment of respiratory tract infections in swine. In addition to 
their potent direct antibacterial activity, some of these antimicrobials, especially 
macrolides and fluoroquinolones, have immunomodulatory effects. 
Immunomodulation refers to the action undertaken by medication on processes that 
guide the immunological defense system. The immunomodulatory capabilities of 
antimicrobial agents have been demonstrated in human cells and, to a lesser extent, in 
animal experiments, especially mice (Zimmermann et al., 2009). 
 
For the purpose of this review, the immunomodulatory effects of quinolones will be 
addressed.   Quinolones have been demonstrated to beneficially interact with the 
immune system in vitro and in animal models (Riesbeck, 2002). Specifically, the 
effects of quinolones on porcine phagocytic activity and cytokine production are 
presented below.  
 
Fluoroquinolones are actively accumulated in phagocytes. At clinically achievable 
concentrations, quinolones might affect granulocyte functions (e.g., phagocytosis or 
chemotaxis). Bacteria pre-incubated with quinolones are also more easily 
phagocytized compared to untreated controls (Riesbeck, 2002). Enrofloxacin is a 
fluoroquinolone routinely used for the treatment of respiratory bacterial infections in 
pigs and other livestock species and poultry. In a study evaluating the effects of 
enrofloxacin on porcine phagocytic function, this antimicrobial was shown to 
accumulate in porcine polymorphonuclear leukocytes (PMNs) and alveolar 
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macrophages (AMs) when clinically relevant concentrations of enrofloxacin were 
used (Matera et al., 1996; Garcia et al., 1992). In addition, intraphagocytic killing of 
A. pleuropneumoniae was significantly enhanced by enrofloxacin in both PMNs and 
AMs (Schoevers et al., 1999). More research is needed to investigate whether these 
effects would also apply to other swine bacteria such as H. parasuis.   
 
Fluoroquinolones have also been shown to have modulatory effects on cytokine 
release. Cytokines are essential elements of the effective immune response against 
infections in general. However, prolonged production of cytokines may result in 
exacerbation of inflammatory reactions and tissue damage (Williams, 2005). As 
explained before, cytokine production represents one immunological factor that 
directs the particular type of immune response by controlling the differentiation of 
precursor T helper (Th0) cells into Th1 or Th2 cells. As a result, antimicrobials that 
affect cytokine production may alter the Th response induced by microbial infection. 
Williams et al. (2005) have shown that the quinolone agents, moxifloxacin and 
ciprofloxacin, have pronounced effects on Th1 and Th2 cytokine expression in human 
mononuclear cells. Both quinolones decreased the number of cells expressing IL-4 
and IFN-γ in stimulated cells compared to control cells without antimicrobials. 
Despite the changes in the number of cells expressing IFN- γ and IL-4, there was no 
significant change in the ratio of the number of INF-γ-positive to IL-4-positive cells 
(Th1/Th2 ratio) in cells exposed to moxifloxacin or ciprofloxacin. These results have 
shown that both quinolones can have effects on Th cell cytokines, with potential 
implications for immune response and recovery after severe infection, but the 
mechanisms of such effects need further investigation. 
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Additional control of cytokine production by fluoroquinolones may have a significant 
role during septic shock. Septic shock that results from Gram-negative bacterial 
infections including H. parasuis has been reported in pigs (Post, 2012). Two 
important mediators of septic shock are tumor necrosis factor (TNF) and interleukin-1 
(IL-1); inducing changes that are similar to those induced by endotoxin (Khan et al., 
2000). Although concentrations of cytokines fluctuate during sepsis, TNF, IL-1, IL-6, 
and IL-10 are frequently elevated in individuals in septic shock (Khan et al., 2000). In 
vitro studies have shown that the fluoroquinolone trovafloxacin reduces cytokine 
production by lipopolysaccharide (LPS)-treated human monocytes, especially IL-1, 
IL-6, IL-10 and TNF-α (Khan et al., 1998). Moreover, the fluoroquinolones 
ciprofloxacin, trovafloxacin and tosufloxacin have been shown to significantly reduce 
the IL-6 and TNF-α serum concentration in quinolone-treated mice injected with LPS, 
and increase the survival of mice receiving lethal dosages of LPS (Khan et al., 2000). 
The mechanisms by which these antimicrobials contribute to protection in LPS-
injected mice are not clear (Khan et al., 2000). 
 
1.4 Summary 
H. parasuis is considered one of the most important bacterial pathogens affecting 
pigs. Vaccines and other management strategies have not always been successful in 
controlling the losses associated to H. parasuis. The success of H. parasuis controlled 
exposure in preventing mortality during the nursery stage suggests that early 
colonization with virulent H. parasuis protects pigs from developing disease. We 
speculate that colonization primes a protective immune response. Therefore, factors 
that may interfere with colonization may interfere with the development of an 
effective immune response. Furthermore, the use of antibiotics has been shown to 
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alter H. parasuis colonization patterns. We hypothesize that disruption of H. parasuis 
colonization by antibiotics might hinder the development of priming immunity by 
rapidly eliminating the source of bacterial antigens. 
 
We reviewed information to determine whether disruption of colonization could be 
important in Glasser's disease. Recent publications show that antibiotics can prevent 
the development of protective immune response against infection with agents, such as 
A. pleuropneumoniae, C. trachomatis and Salmonella sp. Because antibiotic use is 
widespread in the swine industry and it is used as an option to control H. parasuis 
disease, we speculate that selected antibiotic schemes may result in subsequent H. 
parasuis associated disease. Moreover, serum antibody response is important for 
protection against H. parasuis, even though little is known about immune response to 
H. parasuis colonization. Furthermore, although there are studies showing that 
antibiotics reduce nasal colonization with H. parasuis, there is no information on the 
effect of antibiotics on H. parasuis immunity. An improved understanding of whether 
H. parasuis colonization may prime an immune response that will be protective and 
whether this response may be impaired by the use of antibiotics will contribute to the 
development of better control programs for H. parasuis in the field and will help 
develop judicious antibiotic treatment practices. 
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CHAPTER 2  
ROLE OF OLIGOPEPTIDE PERMEASE A (OPPA) PROTEIN IN 
HUMORAL IMMUNE RESPONSE TO HAEMOPHILUS PARASUIS IN PIGS 
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(OppA) protein in humoral immune response to Haemophilus parasuis in pigs. 
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Abstract 
Haemophilus parasuis is an important swine pathogen that causes Glasser's disease, 
characterized by pneumonia, polyserositis and meningitis. Protection against H. 
parasuis infection is associated with the presence of homologous antibodies in serum. 
However, a H. parasuis antigen that can elicit a protective immune response against 
all H. parasuis strains has yet to be found. A novel immunogenic and species-specific 
H. parasuis protein was identified by screening H. parasuis whole cell proteins using 
swine convalescent sera. One protein of 52 KDa was clearly immunodominant and 
conserved among different H. parasuis strains. This protein was further identified as 
an oligopeptide permease A (OppA). Because OppA elicited a specific antibody 
response in pigs that recovered from H. parasuis infection, we investigated its 
potential role in diagnostics and protective immunity. An ELISA test using 
recombinant OppA as its coating antigen was further developed and tested. H. 
parasuis specific antibodies to rOppA were detected in serum from convalescent pigs 
but not in serum from specific pathogen free (SPF) or conventional pigs. Pigs 
immunized with rOppA protein had –antibody in serum against rOppA. However, 
challenged pigs were not protected against challenge with pathogenic H. parasuis. We 
conclude that OppA is a universal species-specific H. parasuis immunogen, and a 
good marker for previous systemic infection with H. parasuis. 
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Introduction 
Haemophilus parasuis is an important swine pathogen that causes Glasser's disease, a 
systemic disease characterized by pneumonia, polyserositis and meningitis (Oliveira 
and Pijoan, 2004). High mortality and morbidity caused by H. parasuis infections are 
common, often in association with viral infections, such as porcine reproductive and 
respiratory syndrome virus (PRRSV) and influenza A virus (IAV) (Solano et al., 
1998; Oliveira and Pijoan, 2004). Control of Glasser's disease is complicated by the 
lack of cross protection between the multiple genetically distinct strains, and the 
limited knowledge on virulence factors and protective antigens (Costa-Hurtado and 
Aragon, 2013). The lack of a consistent and accurate serological test to characterize 
the development of protective antibodies in sows and piglets also makes the control of 
H. parasuis a permanent challenge. 
 
Protection against H. parasuis infection is associated with the presence of 
homologous antibodies against this pathogen (Martin de la Fuente et al., 2009a; 
Nedbalcova et al., 2011). Current commercial vaccines are usually based on bacterin 
extracts of a few strains that do not provide complete cross-protection against all the 
different strains (Bak and Rising, 2002; Hoffman and Bilkei, 2002). Recently, subunit 
vaccines based on immunogenic proteins have gained interest. Specifically, antibodies 
to outer membrane proteins, but not to LPS or capsule, have been associated with 
protection (Miniats et al., 1991). Vaccination of mice or pigs with vaccines containing 
newly identified immunogens such as PalA, Omp2, D15 and HPS-06257 (Zhou et al., 
2009), recombinant transferrin-binding protein (rTbp) (Frandoloso et al., 2011), VtaA 
(Olvera et al., 2011), rSmpA, rYgiW and rFOG (Yuan et al., 2011), rGAPDH, rOapA 
and rHPS0675 (Fu et al., 2013), resulted in partial protection only. Therefore, the 
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identification of novel H. parasuis immunogens is still needed for the development of 
efficacious control methods for H. parasuis.  
 
Oligopeptide-biding proteins belong to the ATP-biding cassette (ABC) family of 
transporters (Monnet, 2003). Oligopeptide permease A (OppA) protein, one of several 
subunits of ABC transporters, is a transmembrane protein in Gram-negative bacteria. 
Previous studies have reported the ability of OppA to elicit immune responses against 
a variety of bacteria, including Yersinia pestis (Tanabe et al., 2006) and Borrelia 
burgdorferi (Nowalk et al., 2006). Specifically for H. parasuis, OppA has been shown 
to induce an immune response in immunized mice (Hong et al., 2011). However, the 
immune response against H. parasuis OppA in the natural host, the pig, has not been 
investigated. Furthermore, the ability of such an immune response to protect pigs 
from H. parasuis disease remains unknown. In this study, we identified the immune 
response against H. parasuis OppA in pigs after they survived a systemic infection 
under field conditions. We also evaluated the potential of OppA as an ELISA antigen 
candidate and its capacity to confer protection to pigs against H. parasuis lethal 
challenge. 
 
Material and Methods 
Farm and pig selection, sample collection and H. parasuis isolation 
A North American swine herd experiencing high nursery mortality (>5%) was 
selected. Clinical signs in affected nursery pigs included fever, respiratory distress, 
lameness, and central nervous system signs. Lesions included mostly fibrinous 
polyserositis. Glasser’s disease was confirmed by culture of H. parasuis from affected 
organs.  Mortality was mainly observed between 5-6 weeks of age. 
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During a first farm visit, 20 pigs presenting clinical signs of H. parasuis disease were 
selected. Pig selection was based on clinical signs characteristic of H. parasuis 
infection (described above) and rectal temperature higher than 105° F. Ten pigs were 
euthanized and necropsied, and the other 10 pigs were bled and treated with ceftiofur 
crystalline free acid (Excede® for swine, Zoetis, Florham Park, New Jersey, USA), at 
5 mg/kg of body weight, intramuscularly. Samples for H. parasuis isolation included 
swabs from heart, brain, pleura, lung, joint and pericardium. In a follow up visit three 
weeks later to the same farm, convalescent sera were collected from the pigs treated 
with ceftiofur.  
  
After collection, swabs were placed in Stuart medium and transported under 
refrigeration to the laboratory, where they were cultured onto 5% sheep blood agar 
plates with a nurse Staphylococcus aureus streak. All plates were incubated at 37°C in 
a 5% CO2 atmosphere.  Plates were checked for the presence of H. parasuis suspect 
colonies at 24 and 48 hours. Suspect colonies showing satellitism to the S. aureus 
nurse streak were isolated onto a new blood agar plate, incubated in similar conditions 
for 24 additional hours, and characterized through biochemical testing. DNA from 
pure cultures was extracted using PrepManTM Ultra Sample Reagent following the 
manufacturer’s instructions and tested by Polymerase Chain Reaction (PCR) as 
described by Oliveira et al. (2001b) to confirm the identity of the pathogen isolated. 
Cultures were harvested and kept frozen at -80°C until use. 
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Genotyping and serotyping  
To evaluate the genetic and phenotypic H. parasuis variability in this herd, and to 
identify the prevalent H. parasuis strain,  H. parasuis isolates were genotyped using 
Enterobacterial Repetitive Intergenic Consensus (ERIC)-PCR (Oliveira et al., 2003b) 
and serotyped by immunodiffusion test using heat stable cell extracts (Raffie and 
Blackall, 2000). Upon completion of ERIC-PCR genotyping, a representative isolate 
from each strain group was selected to be included in sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE) and Western blot analysis for 
protein identification.  
 
Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (SDS-PAGE)  
Whole cell protein profiles of H. parasuis field isolates representative of each strain 
group and H. parasuis reference strains were evaluated using SDS-PAGE (Kawai et 
al., 2004). All H. parasuis isolates were grown under the same conditions described 
above. Overnight cultures were suspended in 1 ml of PBS and vortexed vigorously for 
1 minute. Each suspension was diluted in PBS to achieve a final concentration of 1 
µg/µl, measured by spectrophotometer. Fifty microliter of this suspension was added 
to 50µl of sample buffer containing 47.5µl of Laemmli Sample Buffer (Bio Rad 
Laboratories, Hercules, CA) and 2.5µl of 2-Mercaptoethanol (Bio Rad Laboratories, 
Hercules, CA).  The final solution was boiled for 3 minutes for complete dissociation. 
For SDS-PAGE, 40 µl of the boiled solution was loaded per lane of a gel containing 
4% stacking gel and 10% separating gel (Protean Ready Precast Gel, Jule, Inc, 
Milford, CT). Electrophoresis was carried out in a Protean® II xi Cell equipment (Bio 
Rad Laboratories, Hercules, CA) with a current of 25mA for 30 minutes and 35mA 
for 4 hours. The proteins were visualized by staining with Coomassie Brilliant Blue 
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R-250 1x solution and then destained with Comassie R-250 Destaining solution 1x 
(Bio Rad Laboratories, Hercules, CA).  
 
Western blot analysis using convalescent sera  
Identification of whole cell proteins recognized by the immune system of pigs that 
survived the H. parasuis outbreak was evaluated using Western blot analysis 
according to Towbin et al. (1979). Briefly, following SDS-PAGE analysis, proteins of 
H. parasuis field isolates and reference strains were transferred to PVDF membranes. 
PVDF membranes were blocked with 5% non-fat dried milk (NFDM) (Bio Rad 
Laboratories, Hercules, CA) in Tris-buffered saline (TBS) (Bio Rad Laboratories, 
Hercules, CA) for 2 hours. Sera collected from convalescent pigs were used as 
primary antibodies at 1:50 dilution and incubated with the membrane for 1 hour. The 
membrane was subsequently incubated for 1 hour with anti-Pig IgG-Peroxidase 
antibody (Sigma-Aldrich, St. Louis, MO) diluted 1:1000 as secondary antibody. The 
membranes were stained using the Immun-Blot® Opti-4CNTM Colorimetric Kit (Bio 
Rad Laboratories, Hercules, CA Bio-Rad) following the manufacturer’s instructions. 
After staining the membranes, pictures were taken with a digital camera and the 
membranes were let dry completely. All membranes were stored refrigerated. Serum 
from 1-day-old piglets collected prior to suckling was used as negative control for 
non-specific binding. Western Blot using whole cell proteins extracted from bacterial 
pathogens commonly isolated from swine was performed for specificity. Specificity 
testing included Pasteurela multocida, Bordetella bronchiseptica, Actinobacillus 
pleuropneumoniae, Actinobacillus idolicus, Actinobacillus minus, Actinobacillus suis, 
Actinobacillus porcinus, Escherichia coli, Salmonella choleraesuis, and 
Streptococcus suis. 
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Protein identification, cloning and expression  
An immunodominant protein recognized by convalescent antibodies from naturally 
infected pigs was identified and sequenced. N-amino-terminal sequencing was 
performed directly from this membrane-bound protein utilizing Edman degradative 
chemistry (Oligonucleotide and Peptide Synthesis Facility, BioMedical Genomics 
Center, University of Minnesota). Analysis of protein sequences within GenBank and 
BLAST (Altschul et al., 1990) searches were conducted using NCBI website 
(http://www.ncbi.nlm.nih.gov/BLAST/). 
  
After protein sequencing and identification, the gene encoding for the immunogenic 
protein specific for H. parasuis was purified, cloned and expressed in E. coli. 
(GenScript Corp., Piscataway, New Jersey). Briefly, a synthetic codon-optimized 
version of the immunogenic protein gene was prepared using the OptimumGene™ - 
Codon Optimization technology. A pET-derived vector that attaches an N-terminal 
polyhistidine tag to the protein was used and optimized for expression in Escherichia 
coli. Expression was then induced using IPTG and soluble proteins were isolated by 
Ni–NTA metal-affinity chromatography (Burgess-Brown et al., 2008). The N-
terminal region and tag were then removed by cleavage to obtain high-purified 
protein. The recombinant protein was then analyzed by SDS-PAGE, Western blot and 
sequencing to confirm its identity. 
 
ELISA test development   
After expression of the identified protein specific for H. parasuis, this recombinant 
antigen was used to develop an indirect ELISA test to detect antibodies against this 
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protein. A checkerboard titration was performed to determine the optimal working 
dilution of the coating antigen, serum and anti-pig IgG-Peroxidase conjugate (Sigma-
Aldrich) (HRP-IgG) (Sigma) using a 96-well ELISA plate (Costar 3590 High biding 
96 well EIA/ RIA Plate, flat bottom, Corning Incorporated). The dilutions that gave 
the maximum difference between positive and negative sera by absorbance at 450 nm 
were selected for testing of serum samples.  
  
After optimization, indirect ELISA was performed using the following procedure. 
One hundred nanograms of antigen were diluted in carbonate buffer and each of the 
plate wells were coated with 100 μl. Plates were washed with solution of phosphate 
buffer saline and tween 20 (TPBS) pH 7.4 at room temperature using a microplate 
washer (ELx405TM Biotek) after each incubation step.  The plates were then incubated 
with 300 µl/well of 5% non-fat dried milk (NFDM) in TPBS and allowed to stand for 
2 hours at room temperature. Serum samples were diluted 1:50 in 5% NFDM in PBST 
and 100 μl was added to each well and then incubated for 1 hour. Anti-pig IgG-
peroxidase conjugate (Sigma-Aldrich) was diluted 1:100000 in 5% NFDM in PBST 
and 100 μl were added to each well and incubated for 1 h. Equal volumes of TMB 
peroxidase substrate and peroxidase H2O2 (KPL, Gaithersburg, MD) were mixed 
together and 100 μl were added to each well. The reaction was quenched by adding 
100 μl of 1 M phosphoric acid to each well. The plates were read at 450 nm using a 
microplate reader (ThermoMax Molecular Devices, Sunnyvale, CA).  
 
Sera obtained from convalescent pigs were used as reference positive serum. Sera 
from a 1-day-old colostrum-deprived piglet, and 11 specific pathogen free (SPF) pigs 
were used as reference negative sera. The specificity of this ELISA was examined 
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using sera from 60 healthy pigs that were naturally colonized with H. parasuis in the 
tonsils and had been experimentally infected with A. pleuropneumoniae. 
 
Immunization and challenge of pigs  
All animal experiments were carried out according to the guidelines of the 
Institutional Animal Care and Committee, University of Minnesota. The protective 
efficacy of a vaccine based on recombinant H. parasuis protein was evaluated by 
immunizing 11 weaned pigs by intramuscular injection of recombinant protein (200 
µg) emulsified in oil-in-water adjuvant on day 0. Subsequent booster injections were 
administered on day 14 (Figure 2.1). Another group of 11 pigs was not vaccinated and 
served as positive control. The pigs were housed at the University of Minnesota 
animal research isolation units and were fed ad libitum and with free access to water. 
 
Challenge was performed with the H. parasuis serotype 5 reference strain (Nagasaki), 
passed onto embryonated chicken eggs prior to challenge to increase the expression of 
capsule, a known virulent factor of Gram-negative bacteria (Oliveira and Pijoan, 
2002). Vaccinated and non-vaccinated pigs were inoculated on day 34 of the 
experiment (20 days after the second dose of vaccine) with 1 ml of inoculum 
containing 1010 CFU H. parasuis administered intranasally. Pigs were observed daily 
for clinical signs of disease, such as fever (temperature ≥ 104ºF), respiratory distress, 
lameness, and/or CNS signs, and euthanized on day 41 of the experiment or when 
showing severe clinical signs of disease. 
  
Vaccinated pigs were bled before vaccination and before challenge. Sera were 
separated by centrifugation and stored at -20°C. Sera were tested for antibodies 
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against recombinant H. parasuis protein using a commercially available H. parasuis 
antibody ELISA test kit (Biocheck, Scarborough, ME, USA) developed based on the 
recombinant protein ELISA previously described. 
 
Statistical analysis   
Serology data (OD values) were statistically analyzed for differences between A. 
pleuropneumoniae infected, SPF and convalescent pigs by Kruskal-Wallis test 
followed by Mann-Whitney pairwise comparison and Bonferroni correction 
(p<0.016). Fisher’s exact test was used to compare mortality data and proportion of 
affected pigs between vaccinated and unvaccinated groups in the challenge 
experiment. Mann-Whitney U test was used to compare distribution of ELISA 
sample-to-positive (SP) ratio values between vaccinated and unvaccinated groups 
(p<0.05). ELISA SP values and body temperatures were compared within groups 
throughout the course of infection by repeated measures Friedman’s ANOVA Test, 
followed by multiple pairwise comparisons using Wilcoxon signed rank test with 
Bonferroni correction, p<0.016 for SP values and P<0.007 for body temperatures.    
 
Results 
Bacterial strains, genotyping and serotyping analysis  
All pigs treated with ceftiofur for Glasser’s disease survived the infection. The 
diseased pigs that were necropsied presented lesions characteristic of H. parasuis 
infection, such as polyserositis and arthritis. Twenty-two H. parasuis isolates were 
obtained from eight of the 10 necropsied pigs. ERIC-PCR genomic fingerprints 
revealed seven different genotypes among the 20 isolates. Serotyping analysis 
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revealed that two out of the seven strains belonged to serovar 4 and the remaining 
strains were nontypeable. These seven strains were further analyzed by Western blot. 
 
Detection and identification of a highly immunogenic species-specific protein in H. 
parasuis   
Western blots performed with H. parasuis whole-cell lysate and convalescent sera 
from pigs in the H. parasuis field outbreak resulted in multiple bands ranging from 27 
kDa to 77 kDa. One single band with an estimated molecular weight of 52 kDa, was 
consistently detected and clearly immunodominant in all Western blots using 
convalescent sera from each of the 10 pigs tested against each of the 7 genotypically 
distinct H. parasuis field outbreak strains (Figure 2.2) and 13 distinct H. parasuis 
reference strains (Figure 2.3). No bands were observed in Western blots that used the 
serum of piglets prior to suckling colostrum, indicating lack of non-specific reactions 
with porcine serum (Figure 2.4). Additionally, convalescent sera did not recognize 
this 52 KDa protein in any protein preparations from P. multocida, B. bronchiseptica, 
A. pleuropneumoniae, A. idolicus, A. minus, A. suis, A. porcinus, E. coli, S. 
cholerasuis and S. suis (Figure 2.5).   
  
The 52-kDa protein from all seven outbreak strains and two reference strains 
(serotype 3, a non-virulent strain and serotype 5, a highly virulent strain) was 
subjected to N-terminal amino acid sequence analysis. The partial sequences obtained 
were blasted using NCBI database and the complete sequence was deduced by 
comparison with H. parasuis serovar 5 SH0165 genomic sequence (Yue et al., 2009). 
This protein was consistently identified as oligopeptide permease A (OppA) in the 
GenBank. The OppA gene codes for this protein, which is a transmembrane protein 
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responsible for transporting and internalizing 3-5 amino acid molecules in bacteria 
(Higgins and Hardie, 1983). The complete nucleotide and amino acid sequences for 
OppA had approximately 1584 base pairs and 527 amino acids, respectively. BLAST 
searching on GenBank for nucleotide sequences producing significant alignments 
matched H. parasuis SH0165 (CP001321.1) with 100% identity, and H. parasuis 
ZJ0906 (CP005384.1) with 99% identity. The subsequent closest match was A. 
pleuropneumoniae serovar 7 str.AP76 (CP001091.1) with 69% identity. BLAST 
searching of GenBank for non-redundant protein sequences revealed the highest 
amino acid sequence identity of 99% with H. parasuis OppA protein, followed by 
51% identity with Mannheimia granulomatis (WP027074235.1), and by 49% identity 
with A. pleuropneumoniae (WP005608218.1).  
 
In house ELISA analysis  
The OppA ELISA was able to detect antibodies against H. parasuis OppA in sera 
from the 10 convalescent pigs with OD values ranging from 0.21 to 1.20. Levels of 
specific IgG antibodies against H. parasuis rOppA protein were statistically higher in 
convalescent pigs (mean OD 0.59) than in healthy pigs nasally colonized with H. 
parasuis (mean OD 0.07) or SPF pigs (mean OD 0.02) (p<0.016) (Figure 2.6). The 
colostrum-deprived piglet also had a very low antibody level (OD 0.02). 
 
Recombinant OppA confers no protective immunity in a pig model  
Piglets harbored H. parasuis in their noses at the beginning of the study, but tested 
negative for antibodies against OppA in serum by ELISA prior to inoculation. All 
pigs vaccinated with rOppA protein seroconverted two weeks after the second dose of 
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vaccine (SP ratio > 0.5) (Figure 2.7). Non-vaccinated pigs did not have antibodies 
against rOppA protein. 
  
Challenged pigs had fever and mean rectal temperature reached the highest point for 
non-vaccinated and vaccinated pigs at 2 and 4 days post-infection (DPI), respectively 
(Figure 2.8). On 2 DPI, one pig from the vaccinated group was lethargic and 
hypothermic and it was euthanized. No gross lesions were observed. On 4 DPI, one 
non-vaccinated pig presented nervous clinical signs and two vaccinated pigs presented 
swollen joints and respiratory distress and were euthanized. Moderate amounts of 
turbid fluid and fibrin within pleural, pericardial and peritoneal cavities and joints 
were observed in these pigs. The remaining 18 pigs did not show severe clinical signs. 
They were euthanized 7 days post-challenge. The main lesion found in these pigs was 
pneumonia, observed in 5 out of 18 pigs (4 control and 1 vaccinated pigs). Only pigs 
that presented clinical signs and/or lesions at necropsy (four control and five 
vaccinated) tested positive for H. parasuis by PCR from swabs collected from 
systemic sites at necropsy. Nevertheless, there were no differences between 
vaccinated and non-vaccinated groups on clinical signs, lesions or mortality (Table 
2.1, p>0.05).  
 
Discussion  
In this study, the OppA, a 52-kDa protein, was identified in H. parasuis by screening 
whole cell proteins from virulent strains using convalescent sera from pigs. This 
protein was highly immunogenic, specific to H. parasuis and found in multiple 
serotypes. Antibodies against OppA were found only in pigs infected systemically, 
and not in healthy pigs colonized with H. parasuis in the upper respiratory tract. 
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Therefore, detection of OppA antibodies can be used as a diagnostic marker of 
systemic infection.  
  
The OppA protein, with a total length of 1584 bp, belongs to the ATP-binding 
cassette (ABC) transporter systems. These oligopeptide transport systems are 
composed of five subunits: OppA, OppB, OppC, OppD and OppF, OppA being the 
extracellular biding subunit, responsible for capturing substrates from the 
environment (Monet, 2003). Even though the exact localization of H. parasuis OppA 
protein is unknown, oligopeptide-binding proteins are usually localized in the 
periplasm of Gram-negative bacteria, the region between the plasma membrane and 
the outer membrane of the bacterial cell. These proteins utilize energy from ATP 
hydrolysis to transport a variety of substances across the membrane (Monnet, 2003). 
The role of OppA in the development of protective immunity is unclear since most 
immunogenic proteins in Gram-negative bacteria are associated with the outer 
membrane. However, immunization of mice with OppA resulted in a protective 
immune response against Yersinia pestis (Tanabe et al., 2006). Anti-OppA antibodies 
are also present in convalescent sera of human patients that have recovered from 
systemic infections with Y. pestis (Tanabe et al., 2006) and Borrelia burgdorferi 
(Nowalk et al., 2006). Specifically for H. parasuis, Hong et al (2011) identified OppA 
as a potentially immunogenic protein through an approach different than the one 
described in the present study. In that study, OppA was identified through reverse 
vaccinology and its immunogenicity was demonstrated in mice. In our study we 
confirmed the immunogenicity of this protein in the pig, H. parasuis natural host 
species. However, a strong anti-OppA immune response was not able to protect pigs 
against a challenge with virulent H. parasuis.  
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The purified, rOppA protein was further used to track anti-H. parasuis OppA 
antibodies in serum by ELISA. All convalescent pigs had antibodies against the H. 
parasuis rOppA antigen, while sera from a colostrum-deprived piglet, SPF pigs and 
from A. pleuropneumoniae infected, H. parasuis colonized pigs had undetectable to 
very low levels of antibody against rOppA (Figure 2.6). Specific binding of pig IgG 
antibodies against H. parasuis rOppA and lack of cross-reaction with IgG against A. 
pleuropneumoniae was clearly demonstrated. Interestingly, the A. pleuropneumoniae 
infected pigs used in this study were colonized with H. parasuis in the tonsils. 
Therefore, these results are indicative that pigs colonized with H. parasuis, and have 
not gone through a systemic infection, do not develop anti-OppA antibodies. In 
contrast, pigs that have survived a systemic infection are consistently positive for 
OppA antibodies. For that reason, H. parasuis OppA ELISA can be useful to track 
systemic infection against different serotypes and strains of H. parasuis. H. parasuis 
serologic profiles were recently assessed using the commercial H. parasuis OppA 
ELISA. The commercial H. parasuis OppA ELISA kit detected maternally derived 
antibodies following either H. parasuis vaccination with a live H. parasuis vaccine or 
autogenous killed vaccine (Galina Pantoja et al., 2014). In this study, healthy pigs 
colonized with H. parasuis but not infected, did not have antibodies against OppA, 
which is in agreement with our results.  
 
Universal antigens such as OppA are highly desirable for vaccine development, 
especially regarding H. parasuis, a highly heterogeneous species (Oliveira et al., 
2003b; Mullins et al., 2012; Boerlin et al., 2013).The robust antibody response to 
rOppA protein immunization shows that it is highly immunogenic in swine. However, 
OppA protein seroconversion did not translate to protection against H. parasuis 
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infection in the vaccine trial. Protective immunity to H. parasuis infection has been 
established to be mediated by antibodies (Martin de la Fuente et al., 2009a; 
Nedbalcova et al., 2011), but a H. parasuis antigen that is able to elicit complete 
protective immunity against all H. parasuis strains still has not been identified. In 
order to develop a more efficient subunit vaccine, a combination of antigens, each 
antigen inducing protection against a fraction of isolates, might be needed.  
 
In summary, a highly immunogenic and species-specific protein in H. parasuis was 
identified by screening pig’s convalescent sera for antibodies against H. parasuis 
specific proteins. OppA was further characterized by sequencing, cloning and 
purifying the immunogenic protein. We also demonstrated the diagnostic potential of 
H. parasuis OppA through the development of a species-specific serological test that 
can be used to characterize antibody profiles against H. parasuis. However, OppA did 
not show potential as a vaccine antigen since it was unable to elicit a protective 
immune response. 
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Table 2.1. Serological status and clinical outcome of intranasally inoculated pigs with 
Haemophilus parasuis with and without previous vaccination with OppA vaccine.  
 
Group 
Mean IgG SP 
ratioa 
Number of pigs 
euthanizedb  
Number of pigs 
with gross lesionsc 
Non-vaccinated 0.00 1/11 4/11 
Vaccinated 5.94 3/11 4/11 
aMean antibody response (SP ratio) of pigs on day 28 of the experiment 
bRefers to pigs that had to be euthanized because of severe clinical signs. Pigs 
showing no severe clinical signs were euthanized at the scheduled necropsy day, day 
41.  
cGross lesions observed at necropsy 
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Figure 2.1. Vaccination with recombinant recombinant OppA protein, challenge with 
Haemophilus parasuis and necropsy schedule. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
55 
 
Figure 2.2. Demonstration of immunogenic proteins in 7 Haemophilus parasuis field 
strains obtained from brain (BR), pleura (PL), and pericardium (PC) and 1 swine 
related bacterium species Actinobacillus indolicus (AI) by Western blot with 
convalescent serum from a pig that survived a H. parasuis systemic infection. 
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Figure 2.3. Detection of an immunogenic protein in 13 Haemophilus parasuis 
reference strains by Western blot with convalescent serum from a pig that survived a 
H. parasuis systemic infection. Serotypes are indicated in each lane.  
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Figure 2.4. No non-specific detections by Western blot were observed. Haemophilus 
parasuis field strains obtained from brain (BR), pleura (PL), and pericardium (PC) 
and 3 reference strains (serotypes 3, 5, and 12). 
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Figure 2.5. Specificity testing by Western blot using serum from a convalescent pig 
that survived a Haemophilus parasuis infection. An immunogenic protein was 
detected in a H. parasuis strain isolated from brain (BR7) and in the reference strain 
for serotype 5 (Ser 5). No immunogenic proteins were detected in Actinobacillus 
porcinus (AP), Actinobacillus indolicus (AI), Actinobacillus minor (AM), 
Actinobacillus pleuropneumoniae (APP), Actinobacillus suis (AS), Streptococcus suis 
(SS), Bordetella bronchiseptica (BB),  Pasteurella multocida (PM), Escherichia coli 
(EC), Salmonella choleraesuis (SC).  
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Figure 2.6. Mean OD ELISA values against Haemophilus parasuis recombinant 
OppA in serum (Mean ± 1 SE). Actinobaciluus pleuropneumoniae (App) infected 
pigs, positive for H. parasuis in nasal cavity (colonized) (group 1, n=80), SPF pigs 
(group 2, n=11) and H. parasuis convalescent pigs (Group 3, n=10). Different letters 
represent statistical differences between groups (p<0.01).  
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Figure 2.7. Recombinant OppA-specific antibodies measured by ELISA in weaned 
pigs. Pigs were vaccinated with rOppA subunit vaccine on days 0 and 14 of the study. 
Results show average SP ratio +/- 1 standard error (SE). *Indicates significant 
differences between groups (P<0.01). 
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Figure 2.8. Body temperature (mean ± standard error) measured every day after 
challenge for group 1 (non-vaccinated) and group 2 (vaccinated). *Indicates 
significant differences within groups compared to baseline (day 34) (P<0.007). 
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CHAPTER 3 
EXPERIMENTAL COLONIZATION OF CONVENTIONAL PIGS WITH 
PATHOGENIC HAEMOPHILUS PARASUIS 
 
 
Macedo N, Rovira A, Torremorell M. Experimental colonization of conventional pigs 
with pathogenic Haemophilus parasuis. [In preparation] 
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Abstract 
Glasser’s disease is a swine illness caused by the bacterium Haemophilus parasuis. 
Pathogenic strains of H. parasuis colonize the upper respiratory tract (URT) of 
healthy pigs and, under certain conditions, can spread systemically and cause 
Glasser’s disease. Experimental inoculation models described for H. parasuis are 
designed to develop the disease and not to create an asymptomatic colonization of the 
URT. Therefore, the primary objective of this study was to develop an experimental 
model of pathogenic H. parasuis infection that mimics URT colonization in 
conventional pigs. Sixteen conventional weaned pigs were divided into 3 groups. At 
day 0 of the study, pigs in groups 1 and 2 (n=6 each) received 104 or 106 CFU of 
highly virulent H. parasuis strain Nagasaki intranasally, and group 3 (n=4) received 
saline.  Clinical evaluations and bacterial isolation from nasal swabs were performed 
daily and all H. parasuis isolates obtained were characterized by ERIC-PCR 
genotyping. ERIC-PCR genotyping demonstrated that pigs carried a commensal H. 
parasuis strain. This strain was frequently isolated before and after inoculation from 
the nose of all the pigs throughout the study. The Nagasaki strain, also identified by 
ERIC-PCR, was recovered from the nose of five pigs after inoculation and from 
tracheal swabs from ten pigs collected at necropsy. Overall, the Nagasaki strain was 
isolated at least once from the URT of all 12 inoculated pigs, but was never recovered 
from systemic sites, nor control pigs or before inoculation. There were no differences 
in isolation of the Nagasaki strain based on inoculation dose. No fever or clinical 
signs were observed in any of the pigs throughout the study. The absence of fever, 
clinical signs, lesions and bacteremia demonstrated that there was no systemic 
infection. In summary, the inoculation model described reproduced URT colonization 
with a pathogenic H. parasuis strain without causing systemic disease. This model 
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should prove useful to study factors that mediate H. parasuis colonization and 
expression of Glasser’s disease.  
 
Introduction  
Glasser’s disease is a serious swine illness caused by the Gram-negative bacterium 
Haemophilus parasuis. Glasser’s disease is characterized by fibrinous polyserositis, 
arthritis and meningitis (Oliveira and Pijoan, 2004). Numerous strains of H. parasuis 
have been described through genotypic and phenotypic methods, some of which are 
pathogenic, while others are not (Oliveira et al., 2003, Olvera et al., 2006). Most 
conventional pigs harbor non-pathogenic H. parasuis in their noses (Amano et al., 
1994; Vahle et al., 1997), tonsils (Macedo et al., 2014) and trachea (Segales et al., 
1997). However, pathogenic strains also colonize the upper respiratory tract (URT) of 
healthy pigs (Oliveira et al., 2003a) and, under certain conditions, can spread 
systemically and cause Glasser’s disease. The conditions that favor the development 
of disease are currently unknown. Several hypotheses have been suggested such as 
infection with a new strain when maternal antibodies wane or are no longer present 
(Pijoan et al., 1997, Blanco et al., 2004), co-infection with other pathogens (Yu et al., 
2012), and certain uses of antibiotics (Macedo et al., 2014). Because of the complex 
nature of this problem, these hypotheses can only be tested by using an experimental 
model that can reproduce colonization of the URT with pathogenic H. parasuis under 
controlled conditions. 
 
Numerous experimental inoculation models have been described for H. parasuis. 
However, they are all designed to develop the disease and not to create an 
asymptomatic colonization of the URT. In addition, most of these models use 
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cesarean-derived colostrum-deprived (CDCD) (Vahle et al., 1995; 1997), naturally-
farrowed artificially-reared (Oliveira et al., 2003a) or specific pathogen free (Nielsen, 
1993; Amano et al., 1996; 1997) pigs, which may not fully represent the conventional 
pig in terms of the immune response and the bacteriological nasal flora. Therefore, the 
primary objective of this study was to develop an experimental model of pathogenic 
H. parasuis that mimics nasal colonization in conventional pigs. The development of 
a pig model that preserves the status of conventional pigs will be a valuable tool to 
study H. parasuis colonization and development of disease. 
 
Materials and Methods 
Experimental animals 
Sixteen 3-week-old conventional pigs were selected from a commercial swine herd.  
This herd was free from significant swine pathogens, including influenza virus, 
porcine reproductive and respiratory syndrome virus and Mycoplasma 
hyopneumoniae, and had no history of Glasser’s disease. The pigs were housed at the 
University of Minnesota animal isolation facility (Saint Paul, MN, USA) with each 
group placed in a separate isolation room. The pigs were identified and assigned to 
three groups of six or four pigs each. Pigs received feed and water ad libitum 
throughout the study. All pigs were monitored daily and cared for according to the 
University of Minnesota approved IACUC (Institutional Animal Care and Use 
Committee) protocols.  
 
Bacterial strain 
The H. parasuis Nagasaki strain was selected for the inoculation of piglets because of 
its known virulent properties. This strain has been extensively described in the 
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literature as highly virulent for its ability to cause polyserositis and sudden death in 
pigs (Amano et al., 1997; Martin de la Fuente et al., 2009a; Frandoloso et al., 2011; 
Olvera et al., 2011), invade endothelial (Vanier et al., 2006; Aragon et al., 2010; 
Frandoloso et al., 2013) and epithelial (Frandoloso et al., 2012b) cells in vitro,  
survive phagocytosis (Olvera et al., 2009), be resistant to serum (Cerda-Cuellar et al., 
2008) and possess the virulent group 1 vtaA gene (Olvera et al., 2010).  
 
Before inoculation, Nagasaki strain was passaged in chicken eggs according to 
Oliveira and Pijoan (2002). Briefly, Nagasaki strain was grown on chocolate agar and 
incubated at 37°C in a 5% CO2 atmosphere for 18 hours. Bacterial growth was 
harvested from plates and suspended in sterile PBS. Ten-day old embryonated 
chicken eggs were inoculated through the chorio-allantoid membrane (CAM) using 
0.2 ml of a bacterial suspension containing 109 colony-forming units (CFU)/ml of 
bacteria. Inoculated eggs were incubated at 37°C for 72 hours. Following the 
incubation period, eggs were opened and swabs were taken from the CAM. Swabs 
were cultured on blood agar with a Staphylococcus aureus streak in order to check the 
purity of the inoculum and then on chocolate agar. Bacterial growth was harvested 
from chocolate agar plates and frozen at -80°C until use. One tube from each culture 
was thawed and a standard bacterial count was performed. Original cultures were 
diluted to produce inocula containing 104 and 106 CFU/ml.  
  
Inoculation of piglets 
Pigs were inoculated with 1 mL of 104 CFU/ml of Nagasaki strain inoculum (low dose 
group (LD), n=6), 1.0 mL of 106 CFU/ml of Nagasaki strain inoculum (high dose 
group (HD), n=6), or 1 mL of sterile saline (control group, n=4) at day 0 of the study 
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(Figure 3.1). Inoculum was administered intranasally (0.5 mL in each nostril). Before 
the inoculation, all pigs were sedated by an intramuscular injection in the cervical 
muscles of a dissociative anesthetic at the recommended dose of 6.6 mg/kg (0.06 
ml/kg) (Telazol®, Fort Dodge Animal Health, Fort Dodge, IA). Once sedation was 
achieved (1-2 minutes), pigs were held upright and the inoculum was instilled slowly 
into each nostril using a 1 mL syringe.  
 
Clinical-pathological evaluation and sample collection 
Rectal temperature and clinical signs compatible with Glässer’s disease (cough, 
lethargy, abdominal breath, lameness and nervous signs) were recorded daily after 
bacterial inoculation (day 0). Blood samples were collected at 1, 3 and 4 days post-
inoculation (dpi) to monitor bacteremia by bacterial isolation and PCR. Half of the 
pigs in each group were randomly selected and euthanized at 4 dpi. The remaining 
pigs were euthanized at 7 dpi (Figure 3.1). All pigs were necropsied for evaluation of 
gross lesions with special focus on those potentially attributable to H. parasuis 
infection (Oliveira and Pijoan, 2004). Samples of lung, liver, spleen and kidney were 
collected at necropsy and evaluated for histological lesions.  
 
Nasal swabs were taken before inoculation and daily post-inoculation and assayed for 
the presence of H. parasuis by bacterial isolation. Swabs of nasal cavity, tonsil, 
trachea and serosas (same swab was rubbed on pleura, pericardium, peritoneum and 
joint) were collected postmortem and assayed for the presence of H. parasuis by 
bacterial isolation and PCR (Oliveira et al., 2001b). Additionally, H. parasuis 
isolation was attempted from lung, liver, spleen and kidney samples collected at 
necropsy.  
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Serum samples collected before inoculation and at necropsy were tested for H. 
parasuis antibodies using the BioChek Haemophilus parasuis Oligopeptide permease 
A (OppA) Antibody Test Kit (BioChek, Scarborough, ME), which is based on the H. 
parasuis species-specific protein OppA (chapter 2). Samples with sample to positive 
ratios (S/P) > 0.5 were considered positive. 
 
Isolation and identification of H. parasuis 
For isolation of H. parasuis, swabs were plated onto sheep blood agar streaked with a 
nurse Staphylococcus aureus, cultured and incubated at 37°C in a 5% carbon dioxide 
(CO2) atmosphere for 24 to 48 hours. H. parasuis-like colonies were selected for 
biochemical identification performed as previously described (Oliveira et al., 2001b). 
 
In order to differentiate strain Nagasaki from any other H. parasuis strains that the 
pigs naturally carried, H. parasuis isolates were genotyped by ERIC-PCR (Rafiee et 
al., 2000). H. parasuis isolates were also tested using a multiplex PCR to detect H. 
parasuis group 1 virulence associated trimeric autotransporter (vtaA) gene (Olvera et 
al., 2012). 
 
Statistical analysis 
The proportion of pigs positive based on Nagasaki strain isolation from nose and 
trachea and the proportion of pigs presenting clinical signs of disease including fever 
(rectal temperature above 40°C) were compared by Fisher’s exact test.  
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Results  
H. parasuis colonization 
Prior to inoculation of the Nagasaki strain, nasal swab cultures yielded H. parasuis 
isolates from 14 out of 16 pigs (Table 3.1). These 14 isolates had identical ERIC-PCR 
fingerprint, and were therefore considered one strain, denominated “farm” strain 
henceforward (Figure 3.2A). There were 53 additional isolations of the H. parasuis 
farm strain throughout the study (Table 3.1). After inoculation, the Nagasaki strain 
was first isolated from three different pigs belonging to the LD group at 1, 3 and 5 dpi 
and from one pig from the HD group at 3 dpi (Table 3.1). Nagasaki strain was not 
isolated from control pigs. At necropsy, the Nagasaki strain was recovered from 
tracheal swabs from 11 inoculated pigs, while tonsillar swabs yielded only one isolate 
(Table 3.1). The number of pigs colonized by the Nagasaki strain was significantly 
higher in LD and HD groups when compared to the control group (p=0.005). All pigs 
tested positive by PCR for detection of H. parasuis at the species levels in the nose at 
necropsy, while 15 out of 16 tested positive in the tonsils and half of the pigs tested 
positive in the trachea (Table 3.2). 
 
Absence of H. parasuis systemic infection 
After inoculation, pigs did not have any clinical signs of disease. At necropsy, no 
gross or microscopic lesions were observed. H. parasuis was not isolated from blood 
collected at 1, 3 and 4 dpi or from tissues (liver, spleen, kidney and lung) or serosal 
swabs collected at necropsy from any of the pigs. Serosal swabs also tested negative 
for H. parasuis by PCR (Table 3.2).  Antibodies against H. parasuis antigen OppA 
were not detected before inoculation, or at 4 and 7 dpi. 
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Discussion 
This study showed that conventional pigs can be used as a model to study mucosal 
colonization with a H. parasuis pathogenic strain. H. parasuis frequently colonizes 
the surface of the mucosa of the swine respiratory tract and colonization is considered 
an important pre-requisite for subsequent invasion of host tissues and progression to 
Glasser’s disease (Vahle et al., 1995). However, better understanding of H. parasuis 
disease mechanisms and host immune responses is required. To this end, we have 
established a model of H. parasuis colonization by a pathogenic strain in the absence 
of systemic disease in conventional pigs. 
 
Successful nasal colonization was demonstrated by isolation of the Nagasaki strain at 
least once from the URT of all 12 inoculated pigs between days 1 and 7 post-
inoculation. On the other hand, the absence of systemic spread was evidenced by lack 
of clinical signs, lack of recovery of Nagasaki strain from blood or systemic tissues, 
and lack of gross or microscopic lesions at necropsy.   
 
Because the ideal inoculation dose was previously unknown, two different doses were 
used. There were no significant differences on the number of Nagasaki isolates 
obtained based on inoculation dose. Nagasaki strain has been used before to inoculate 
CDCD pigs at a low dose of 5 x 104 CFU/mL without causing disease, however 
evidence of colonization was not provided in that study (Martin de la Fuente et al., 
2009a). In a different study, inoculation of pigs fed bovine colostrum and milk 
replacer with Nagasaki strain at 104 and 106 CFU resulted in systemic disease 
(Oliveira et al., 2003a). This is the first study to report the use of low dose Nagasaki 
strain to colonize conventional pigs.  
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Therefore, under the conditions of the present study, doses between 104 and 106 
CFU/mL were low enough not to cause systemic infection as well as high enough for 
nasal and tracheal colonization of conventional weaned pigs.  
 
H. parasuis isolation from tonsils was not common in this study, which is in 
agreement with other studies showing that the nasal cavity might be the primary site 
for H. parasuis respiratory mucosal colonization (Vahle et al., 1995; 1997). However, 
when tonsil swabs were tested by PCR, H. parasuis DNA detection was common 
(Table 3.2). Tracheal swabs yielded higher numbers of Nagasaki isolates than the 
nasal swabs. Previous reports have described the recovery of H. parasuis from trachea 
of CDCD pigs intranasally inoculated, even though H. parasuis was isolated more 
frequently from nasal cavity (Vahle et al., 1995; 1997). In this study, the H. parasuis 
farm and Nagasaki strains seemed to have a predilection for nasal and tracheal 
mucosa, respectively. Alternatively, the farm strain found naturally in the nose may 
have prevented the Nagasaki strain from stablishing itself in the same environment. 
Additionally, in conventional pigs, trachea might represent a less competitive niche 
for H. parasuis colonization, which may explain why tracheal swabs yielded higher 
number of Nagasaki isolates compared to nasal swabs. 
 
No rise on antibody levels was detected in inoculated or control pigs during the study 
period. This supports the conclusion that pigs were not systemically infected. The H. 
parasuis OppA ELISA test detects IgG antibodies in serum usually 7 to 14 days after 
pigs are systemically infected or vaccinated (chapter 2). Therefore, 7 days may have 
not been enough time to observe seroconversion. However, euthanasia times of 4 and 
7 dpi were selected to maximize the chances of isolating H. parasuis from systemic 
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samples and observing lesions in systemic tissues. Further investigations on other 
immune parameters, such as IgA antibodies and cellular responses, are needed since 
they might play a role on limiting systemic infection.  
 
In summary, in contrast to H. parasuis-free pig models, the colonization model using 
conventional pigs mimics the status of commercial animals. Pathogenic strains of H. 
parasuis can colonize the nose and trachea of conventional pigs for at least 7 days. 
Mechanisms by which pathogenic H. parasuis strains compete with many other 
microorganisms for colonization sites in the URT and invade systemic tissues are not 
well understood. This model should prove useful to study factors that mediate H. 
parasuis colonization and expression of Glasser’s disease.  
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Table 3.1. Summary of type of Haemophilus parasuis isolates obtained from weaned 
pigs throughout the study.  
 
1 Farm strain  
2 H. parasuis isolate recovered from nasal swab unless otherwise specified 
3 No H. parasuis isolation  
4 NAG: Nagasaki strain  
5 Bold specifies isolate recovered at necropsy 
6 Pig euthanized on 4 dpi. 
 
 
 
 
  Days post-inoculation 
Group 
(inoculum 
dose) 
Pig # Pre-inoc. 1 2 3 4 5 6 7 
104 
CFU/mL 
986 Farm1,2 -3  -  - 
NAG5 
NAG/Trachea 
†6 † † 
976 Farm NAG4 Farm Farm NAG/Trachea † † † 
979 Farm - Farm - 
Farm 
 NAG/Trachea 
† † † 
980 Farm Farm Farm NAG Farm Farm Farm NAG/Trachea
975 -  -  Farm -  Farm NAG Farm NAG/Trachea
987 Farm Farm Farm Farm   Farm NAG/Trachea
106 
CFU/mL 
974  -  Farm Farm -   
Farm 
NAG/Trachea 
† † † 
978 Farm Farm Farm Farm 
Farm 
NAG/Trachea 
† † † 
989 Farm Farm - Farm 
Farm 
NAG/Trachea 
† † † 
983 Farm - Farm NAG Farm 
Farm 
 
Farm  
NAG/Trachea
984 Farm -  -  Farm Farm  NAG/Tonsil
988 Farm Farm Farm - Farm Farm Farm 
Farm 
NAG/Trachea
Control 
(PBS) 
977 Farm -  Farm Farm - † † † 
985 Farm - - - - † † † 
981 Farm - Farm Farm Farm Farm Farm -  
982 Farm Farm Farm Farm Farm Farm Farm -  
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Table 3.2. Haemophilus parasuis PCR results from swabs collected from pigs at 
necropsy 4 or 7 days after inoculation with H. parasuis.  
   Swabs collected at necropsy 
Group 
(inoculum dose) 
Necropsy 
day Pig # Nose Tonsil Trachea Serosas 
Lower dose 
 (104 CFU/mL) 
4 
986 + + + - 
976 + + + - 
979 + + - - 
7 
980 + + - - 
975 + - - - 
987 + + + - 
Higher dose (106 
CFU/mL) 
 
4 
974 + + + - 
978 + + - - 
989 + + + - 
7 
983 + + - - 
984 + + + - 
988 + + + - 
Control 
 (PBS) 
4 
977 + + - - 
985 + + - - 
7 
981 + + - - 
982 + + + - 
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Figure 3.1. Haemophilus parasuis colonization model: Experimental design and 
sampling times. aPigs were inoculated with 1.0 mL of 104 CFU/ml or 106 CFU/ml of 
Nagasaki strain or 1.0 mL of sterile saline intranasally at day 0 of the study.  
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Figure 3.2. ERIC-PCR fingerprint profiles of H. parasuis strains in this study (A), 
and results of vtaA Multiplex PCR (B).  MW: Molecular weight marker. Farm: farm 
strain. Nag: Nagasaki strain. Neg: Negative control. 
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CHAPTER 4 
EFFECT OF ENROFLOXACIN ON THE CARRIER STAGE OF 
HAEMOPHILUS PARASUIS IN NATURALLY COLONIZED PIGS 
 
 
This work has been published in: 
Macedo N, Rovira A, Oliveira S, Holtcamp A, Torremorell M. 2014. Effect of 
enrofloxacin on the carrier stage of Haemophilus parasuis in naturally colonized pigs. 
Can J Vet Res 78, 17-22. 
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Abstract 
The purpose of this study was to determine the effect of enrofloxacin in the carrier 
stage of Haemophilus parasuis in naturally colonized weaned pigs. Twenty-three pigs 
colonized by H. parasuis received either 7.5 mg/Kg of enrofloxacin or saline solution 
intramuscularly at weaning. Nasal and tonsillar swab samples were collected daily 
throughout the study and at necropsy and tested by quantitative PCR (qPCR). The H. 
parasuis isolates obtained from samples collected at necropsy were subjected to 
genotyping by enterobacterial repetitive intergenic consensus (ERIC)-PCR, and a 
multiplex PCR for the detection of the vtaA virulence associated trimeric 
autotransporter genes. H. parasuis was detected in the nasal cavity and tonsils of pigs 
in the control group throughout the study. Antibiotic treated pigs tested H. parasuis 
negative at 1 day post treatment (DPT),  and the proportion of nasal samples that 
tested positive was statistically higher for control pigs compared with treated pigs at 
1, 2, 3, 4, 5, 6 and 7 DPT, and at 2, 4 and 5 DPT for tonsil samples (p value < 0.003). 
Genotyping by ERIC-PCR demonstrated that pigs were colonized with a common H. 
parasuis strain at the end of the study. Isolates were negative for the vtaA gene, which 
indicated that they did not have the vtaA virulence factor. In conclusion, enrofloxacin 
significantly reduced the H. parasuis load in naturally colonized pigs, but was unable 
to eliminate the organism. 
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Introduction 
Haemophilus parasuis is an economically significant Gram-negative organism, which 
colonizes the upper respiratory tract of pigs soon after birth (Smart et al., 1988; 
Oliveira et al., 2001a). The presence of humoral immunity generally prevents pigs 
from developing systemic disease (Solano-Aguilar et al., 1999; Cerda-Cuellar et al., 
2010), which is commonly characterized by fibrinous polyserositis, arthritis and 
meningitis (Amano et al, 1994). Stress conditions coinciding with decay of maternal 
immunity, such as weaning and transport (Kirkwood et al., 2001), and co-infections 
with immunosuppressive agents, such as porcine reproductive and respiratory 
syndrome (PRRS) virus (Solano et al., 1998), have been suggested as risk factors for 
systemic invasion of H. parasuis.  
 
Alterations in the carrier stage of H. parasuis at a young age have also been 
associated with the development of Glasser’s disease during the post-weaning period 
(Pijoan et al., 1997). Most of the studies have focused on the effect of early weaning 
in the disruption of the colonization patterns under the presence of maternal 
immunity. In these studies, H. parasuis disease was exacerbated when pigs were 
colonized late when maternal immunity was waning (Oliveira et al., 2001; Cerda-
Cuellar et al., 2010; Blanco et al., 2004). However, there is limited information on 
what other factors may alter the carrier state of H. parasuis.  
 
Antibiotics are commonly used to mitigate the effects of bacterial disease in pigs in 
order to limit bacterial challenge. A recent study has reported that marbofloxacin 
treatment was able to reduce the nasal carriage of H. parasuis in weaned pigs (Vilalta 
et al., 2012). Another fluoroquinolone, enrofloxacin, is a common antimicrobial used 
80 
 
in farms to treat Glasser’s disease in North America. Enrofloxacin is among the 
approved products by the US Food and Drug Administration Center of Veterinary 
Medicine for treatment and control of disease associated with H. parasuis. There is no 
information on what effect enrofloxacin may have specifically on the carrier state of 
H. parasuis in naturally colonized pigs and whether the carrier state is affected at all. 
Thus, the purpose of this study was to evaluate the effect of enrofloxacin in reducing 
H. parasuis colonization in weaned pigs. 
 
Material and Methods 
Animals and animal housing 
Forty five, 1-week-old pigs with a history of Glasser’s disease, porcine reproductive 
and respiratory syndrome (PRRS) virus, porcine circovirus type 2 (PCV2), and 
Mycoplasma hyopneumoniae were identified on a conventional North American farm 
and screened for the presence of H. parasuis in the upper respiratory tract using 
16S ribosomal ribonucleic acid (rRNA) gene polymerase chain reaction (PCR) 
(Oliveira et al., 2001b). The pigs received PCV2 vaccine at 4 days of age and at 
weaning and M. hyopneumoniae vaccine at weaning. Of those 45 pigs, twenty-four 3-
week-old weaned pigs that tested positive for H. parasuis were selected and moved to 
the University of Minnesota research isolation facility. Pigs were randomly divided 
into treatment (n = 12 pigs) and control groups (n = 12 pigs) and housed in two 
separated isolation rooms (1 pig in the control group died shortly after arrival due to 
an unrelated H. parasuis cause). The pigs were fed ad libitum and had free access to 
water. Pigs were cared for according to the guidelines of the Institutional Animal Care 
and Use Committee of the University of Minnesota. 
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Experimental design 
On the day of arrival at the research facility, blood samples and nasal and tonsil swabs 
were collected from all pigs and tested by 16S rRNA gene PCR (Oliveira et al., 
2001b) and qPCR as described in the next section. Pigs in the treatment group were 
treated with a single dose of injectable enrofloxacin (7.5 mg/kg BW Baytril; Bayer 
Animal Health, Shawnee, Kansas, USA) at 24 h post-arrival and those in the control 
group received saline solution intramuscularly. Tonsillar and nasal swabs were 
collected daily. At 3, 7, and 14 d post-treatment, four pigs from each group were 
randomly chosen and euthanized. At necropsy, blood samples and swabs from the 
nasal cavity, interior of the tonsil, trachea, lung, and peritoneal and pleural serosa 
were collected in duplicate. One swab from each organ was used for bacterial 
isolation and the other swab was tested by quantitative PCR (qPCR) as outlined in the 
next section. H. parasuis isolates were further characterized by ERIC-PCR (Rafiee et 
al., 2000) and virulence-associated trimeric autotransporter polymerase chain reaction 
(vtaA-PCR) (Olvera et al., 2012).  
 
Quantitative PCR 
Deoxyribonucleic acid (DNA) from swabs was extracted using DNeasy Blood & 
Tissue Kit (QIAGEN, Hilden, Germany) and then tested individually by qPCR (Turni 
et al., 2010), with modifications. Briefly, primers forward (59-
CGACTTACTTGAAGCCATTCTTCTT-39) and reverse (59-
CCGCTTGCCATACCCTCTT-39) were based on the infB gene of H. parasuis, 
which is also considered to be a genetic marker for phylogenetic studies of species, 
separating H. parasuis from other closely related species. The FAM-labelled TaqMan 
probe with a TAMRA quencher (59-6FAM-
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ATCGGAAGTATTAGAATTAAGTGCTAMRA-39) was supplied by Applied 
Biosystems (Carlsbad, California, USA). The 25-mL reaction mix consisted of 7 mL 
of H2O, 10 mL of master mix, 100 nmol/L of CTinfF1, 400 nmol/L of reverse primer, 
100 nmol/L of forward primer, and 5 mL of template. A standard curve was 
established by a 10-fold serial dilution of known quantities of the H. parasuis 
reference strain Nagasaki extracted DNA. The 7500 Fast System SDS software 
(Applied Biosystems) was used to calculate the quantity of unknown target sequences 
from the standard curve for the detector of that target. The reaction was run with the 
following cycling conditions: first cycle at 95°C for 2 min, followed by 30 cycles of 
95°C for 20 s and 58°C for 60 s, followed by 1 cycle at 28°C for 1 min. All reactions, 
including the standard curve, were run in duplicate. Results are shown in 
CFU/reaction. 
 
H. parasuis isolation and characterization 
For isolation of H. parasuis, samples were plated onto sheep blood agar streaked with 
a nurse Staphylococcus sp. strain, cultured and incubated at 37ºC in a 5% carbon 
dioxide (CO2) atmosphere for 24 - 48 hours. Up to 5 H. parasuis-like colonies per 
agar plate were selected for further identification (Oliveira et al., 2001b). 
Enterobacterial repetitive intergenic consensus-PCR (ERIC-PCR) (Rafiee et al., 2000) 
was used to better characterize H. parasuis isolates. 
 
A multiplex PCR based on vtaA genes (Olvera et al., 2012) was used to differentiate 
the non-virulent from potentially virulent H. parasuis isolates. H. parasuis possesses 
virulence associated trimeric autotransporters (vtaA): group 1 vtaA has been 
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associated with virulent strains; while group 3 vtaA gene is highly conserved among 
H., parasuis strains (Pina et al., 2009).   
 
Enzyme-linked immunosorbent assay (ELISA) 
Blood samples were tested for H. parasuis antibodies using an enzyme-linked 
immunosorbent assay (ELISA) based on the H. parasuis species-specific protein 
OppA (chapter 2), using the Swine SK104 Haemophilus parasuis (OppA) Antibody 
Test Kit (BioChek, Scarborough, Maine). Samples testing sample to positive ratio 
(S/P) > 0.5 were considered positive.  
 
Statistical analysis  
Differences between the proportions of H. parasuis-positive pigs in treated versus 
control groups at each sampling time point were calculated using Fisher’s exact 
probability test. The Bonferroni correction was used to address multiple comparisons 
(α = 0.003). 
 
Results  
Polymerase chain reaction (PCR) targeting the 16S rRNA PCR was used to screen 
naturally colonized pigs at the farm of origin and to confirm their H. parasuis 
colonization status when the pigs arrived at the research facility. Tonsil and nasal 
swabs from all pigs tested positive for H. parasuis by 16 rRNA PCR on the day of 
arrival at the research facilities. No clinical signs of H. parasuis disease (fever, 
anorexia, lameness, thumping) were observed during the experiment.  
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Quantitative PCR was used to detect and quantify H. parasuis in the tonsil and nasal 
cavity during the study period. Before treatment, 22 out of 23 pigs (95.7%) tested 
positive by qPCR from tonsil swabs, while only 11 pigs (48%) tested positive from 
nasal swabs (Figures 4.1 and 4.2). Among the pigs that tested positive before 
treatment, the average H. parasuis load detected in tonsils and nasal cavities was 2.8 x 
105 and 2.3 x 104 colony-forming units (CFUs)/reaction, respectively. Pigs in the 
control group tested positive throughout most of the study, while all treated pigs 
tested H. parasuis negative by qPCR at 1 day post-treatment (DPT) (Figures 4.1 and 
4.2, Table 4.1). The proportion of nasal samples that tested positive was statistically 
higher for control pigs compared with treated pigs at 1, 2, 3, 4, 5, 6 and 7 DPT, and at 
2, 4 and 5 DPT for tonsil samples (p value < 0.003) (Figures 4.1 and 4.2).  
 
At necropsy, no gross lesions were observed and H. parasuis was detected by qPCR 
in 9 out of 11 control pigs in at least 1 of the 5 samples tested (Table 4.2). In contrast, 
only 4 out of 12 pigs in the treatment group tested positive. Interestingly, all 4 H. 
parasuis isolates obtained were recovered from samples collected at necropsy at 15 
DPT, but not in the necropsies prior to that. ERIC-PCR profiles were obtained from 
the four isolates. One single cluster could be distinguished for the four isolates based 
on coverage of 90% agreement (Oliveira et al., 2003b). 
 
The putative virulence factor, the group 1 vtaA gene, was not detected in any of the 
four isolates obtained, while the group 3 vtaA, highly conserved among H. parasuis 
strains, was detected in all isolates. 
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All anti-OppA serum antibody levels, as measured by ELISA S/P on arrival (mean 
S/P = 0.01) and at necropsy (mean S/P control pigs 0.001 versus mean S/P treated 
pigs 0.03) were very low and under the cut-off value of 0.5.  All values were 
considered negative. 
 
Discussion  
In this study, we demonstrated that enrofloxacin reduced the number of H. parasuis in 
the tonsil and nasal cavity of pigs and decreased the number of pigs that were positive 
for H. parasuis by qPCR during the first week after treatment.  
 
The presence of H. parasuis was demonstrated by gel-based PCR in samples from 
tonsils and nasal cavity in all pigs before treatment, while qPCR detected 95.7% 
positives on tonsils but only 48% positives in nasal cavity. Differences in results 
might be due to the lower sensitivity of the qPCR (4 x 103 CFU/mL) compared with 
the gel-based PCR (1 x 102 CFU/mL) (Oliveira et al., 2001b). However, qPCR was 
preferred in order to quantify the effect of the antibiotic on bacterial load. The fact 
that the pigs tested negative after treatment and that some pigs then became positive 
again suggests that the treatment decreased the level of H. parasuis below the 
threshold of qPCR detection, but did not completely eliminate H. parasuis. 
 
These results are in agreement with a study investigating the effect of marbofloxacin 
in the H. parasuis carrier state in pigs at the farm level (Vilalta et al., 2012). Both 
marbofloxacin as well as enrofloxacin in the present study showed a similar 
effectiveness after treatment, reducing the amount of H. parasuis in the nasal cavity 
of pigs, but not eliminating it. 
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The rapid and relatively long effect of enrofloxacin on H. parasuis in the nasal cavity 
and tonsil of pigs can be attributed to enrofloxacin’s tissue penetration, extended half-
life, and rapid bactericidal effect in a concentration-dependent manner and prolonged 
post-antibiotic effect (Walker et al., 2006). Possible explanations for the antibiotic’s 
inability to fully eliminate H. parasuis are that the dose of antibiotic may have not 
reached an adequate concentration at the colonization sites or that enrofloxacin 
induced the emergence of resistant strains. Even though the concentration of 
enrofloxacin in the nasal cavity or tonsil was not assessed in this study, the 
concentration of enrofloxacin in nasal secretions of pigs is considered nearly equal to 
plasma concentrations, suggesting that it was not a dose-effect issue (Bimazubute et 
al., 2009). Additionally, at necropsy, even when cutting the tonsils and collecting 
swabs from inside the tonsils, pigs treated with enrofloxacin tested negative for H. 
parasuis at 4 and 8 d post-infection, which demonstrates that bacteria was not 
concentrated deep in the tonsils soon after treatment. Furthermore, antibiotic 
resistance was not likely since 3 of the 4 H. parasuis isolates recovered at necropsy 
were tested for antimicrobial susceptibility and all 3 isolates were susceptible to 
enrofloxacin. The fourth isolate would not grow in the test medium. 
 
All pigs remained clinically healthy throughout the study and, as expected, most of 
the control pigs tested positive in samples from the upper respiratory tract. 
Furthermore, at necropsy, 5 pigs tested positive in the trachea and 2 pigs tested 
positive in the lung, which confirms that H. parasuis can be detected in the trachea 
and lung of healthy pigs, as reported elsewhere (Oliveira, 2004). In contrast, swabs 
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collected at necropsy from pigs treated with antibiotics only tested positive when 
collected on day 15 of the study. 
 
Pigs in both groups remained serologically negative. The OppA ELISA kit was used 
to monitor H. parasuis systemic infection during the study, since it measures the 
amount of antibodies to the H. parasuis species-specific antigen OppA in pigs 
systemically infected by all H. parasuis serotypes or vaccinated with H. parasuis. 
Healthy (colonized) pigs are not expected to have anti-OppA antibodies. While 
outside the scope of this study, further investigation is required to determine whether 
H. parasuis strains colonizing the upper respiratory tract are able to trigger an 
immune response. 
 
Characterization of all H. parasuis isolates recovered at necropsy indicated that both 
groups were colonized with the same H. parasuis strain. In addition, the isolates were 
negative by the vtaA group 1 PCR, which indicates that these isolates did not have the 
vtaA virulence factor. This result was expected since H. parasuis is a commensal 
organism of the upper respiratory tract and most of the isolates recovered from the 
nose are considered non-pathogenic (Oliveira et al., 2003a). One isolate that was vtaA 
negative was obtained from systemic sites (serosas) in a clinically healthy control pig, 
however, which requires further investigation. 
 
In conclusion, the results of this study indicate that enrofloxacin can reduce the levels 
of H. parasuis in naturally colonized pigs. Reduction of H. parasuis in the upper 
respiratory tract of pigs may help to control the disease during susceptible stages such 
as the weaning period, possibly delaying the infection to a point when the pigs are 
88 
 
able to develop their own active immunity against this organism. Further research is 
needed, however, to evaluate the lasting effect of enrofloxacin in the colonization 
patterns and disease dynamics of H. parasuis. 
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Table 4.1. Daily average colony-forming units (CFUs)/reaction and standard 
deviation (SD) from pigs in treated and control groups. 
 Average CFU/reaction ± (SD) 
 Tonsil Nasal 
Days 
after 
treatment 
Control Treatment Control Treatment 
0 1.8 x 105 (1.5 x 105)a 3.5 x 105 (4.3 x 105) 1.0 x 104 (1.9 x 104) 1.1 x 104 (2.7 x 104) 
1 4.0 x 104 (8.0 x 104) 0c 6.4 x 103 (8.2 x 103) 0 
2 2.0 x 105 (3.8 x 105) 0 1.2 x 104 (1.1 x 104) 0 
3 1.5 x 105 (3.3 x 105) 6.8 x 105b 6.4 x 104 (1.5 x 105) 0 
4 2.3 x 103 (1.7 x 103) 0 3.8 x 104 (2.2 x 104) 0 
5 4.6 x 103 (2.8 x 103) 0 4.0 x 104 (3.3 x 104) 0 
6 8.0 x 103 (1.3 x 104) 0 7.6 x 103 (1.0 x 104) 0 
7 1.8 x 103 (1.8 x 103) 3.9 x 104 1.1 x 104 (1.6 x 104) 0 
8 1.8 x 103b 0 1.2 x 105 (9.3 x 103) 0 
9 7.0 x 103 3.0 x 105 5.1 x 104 (4.2 x 104) 0 
10 2.7 x 104 (2.7 x 104) 0 2.0 x 105 (1.2 x 105) 0 
11 4.6 x 104 (3.5 x 104) 0 2.3 x 105 (8.8 x 104) 1.8 x 104 
12 1.9 x 103 (2.5 x 103) 0 2.9 x 105 (2.7 x 105) 0 
13 3.7 x 103 (3.2 x 103) 2.6 x 103 (3.1 x 103) 4.0 x 105 (1.5 x 105) 3.7 x 104 
14 2.2 x 103 (1.9 x 103) 2.1 x 103 (1.0 x 103) 2.6 x 105 (3.5 x 104) 9.3 x 104 
a Average ± standard deviation. 
b Only one pigs positive in the group. 
c No positive pigs in the group. 
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Table 4.2. Number of pigs detected Haemophilus parasuis positive by qPCR and 
bacterial culture at necropsy.  
Groups Control  Treatment 
Day post-
treatment 
4 
(n=4) 
8 
(n=4) 
14 
(n=3) 
 4 
(n=4) 
8 
(n=4) 
14 
(n=4) 
Nasal 2a (0b) 4 (0) 3 (2)  0 (0) 0 (0) 1 (1) 
Tonsil 2 (0) 3 (0) 2 (0)  0 (0) 0 (0) 3 (0) 
Trachea 1 (0) 1 (0) 3 (0)  0 (0) 0 (0) 1 (0) 
Lung 1 (0) 0 (0) 1 (0)  0 (0) 0 (0) 0 (0) 
Serosae 0 (0) 0 (0) 0 (1)  0 (0) 0 (0) 0 (0) 
a qPCR 
b Bacterial culture 
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Figure 4.1. Percentage of positive pigs by nasal swabs qPCR from control (n=11) and 
treatment (n=12) groups by day. a Differences (p<0.003) between treatment and 
control. 
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Figure 4.2. Percentage of positive pigs by tonsil swabs qPCR from control (n=11) 
and treatment (n=12) groups by day. a Differences (p<0.003) between treatment and 
control. 
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EFFECT OF ENROFLOXACIN ON HAEMOPHILUS PARASUIS 
INFECTION, DISEASE AND IMMUNE RESPONSE 
 
 
Macedo N, Cheeran M, Rovira A, Torremorell M. Effect of enrofloxacin on 
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Abstract 
Haemophilus parasuis is a pathogen that colonizes the upper respiratory tract (URT) 
of pigs and, through mechanisms not well understood, invades the bloodstream and 
causes polyserositis. This syndrome is known as Glasser’s disease. Antimicrobial 
treatment is widely used to treat Glasser’s disease, but the effects of early elimination 
of H. parasuis before immunity is activated are not known. We characterized the 
antibody and IFN-γ responses to H. parasuis in pigs treated with enrofloxacin before 
or after low dose inoculation with a pathogenic H. parasuis strain to better understand 
the effect of enrofloxacin on immune response to H. parasuis. Pigs that were 
inoculated only (EXP group) and pigs that were treated with enrofloxacin and then 
inoculated (ABT/EXP group) developed signs of disease starting at 4 days post 
inoculation (DPI). Pigs from these groups also presented a significant increase on 
levels of serum IgG. This seroconversion was associated with protection against 
challenge. In contrast, pigs treated after inoculation (EXP/ABT group) did not have 
signs of disease or seroconverted after inoculation. EXP/ABT pigs as well as naïve 
control pigs [enrofloxacin only (ABT) and challenge only (CHA)] were susceptible to 
challenge. Variable levels of serum IgA antibodies, IgG and IgA in bronchioalveolar 
fluid (BALF) and IFN-γ responses were observed after H. parasuis inoculation in the 
different groups, but the values were not associated with protection. After low dose 
inoculation, the virulent H. parasuis strain was isolated from most of inoculated pigs. 
However, enrofloxacin given after H. parasuis inoculation eliminated H. parasuis 
from the noses and larynges of treated pigs. In summary, enrofloxacin treatment 3 
days before H. parasuis inoculation did not interfere with H. parasuis infection and 
subsequent seroconversion and protection against challenge. However, pigs treated 
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with enrofloxacin after H. parasuis inoculation did not seroconvert and were 
susceptible to challenge.  
 
Introduction 
Haemophilus parasuis is a Gram-negative bacterium that causes Glasser’s disease in 
pigs. The disease is characterized by fibrino-purulent polyserositis, arthritis and 
meningitis leading to high mortality and morbidity, which results in significant 
economic losses to pig producers. Pathogenic and non-pathogenic H. parasuis strains 
can be isolated from the upper respiratory tract of healthy pigs (chapters 3 and 4). 
Stress conditions such as weaning and transport have been suggested as risk factors 
for H. parasuis systemic dissemination (Aragon et al., 2012).  However, the 
mechanisms involved in the systemic invasion of H. parasuis are largely unknown. 
 
Vaccines against H. parasuis are available and can be used for prevention. However, 
control of Glasser’s disease through vaccination can be difficult, especially because 
there are many strains and subtypes, and cross-protection among isolates is limited. In 
contrast, field studies demonstrated that inoculating piglets with a low dose of a live 
pathogenic H. parasuis strain reduced nursery mortality due to Glasser’s disease 
(Oliveira et al., 2001; Oliveira et al., 2004). The mechanism behind such protection 
was not determined, but it was hypothesized that such exposure results in H. parasuis 
colonization, which may elicit a protective immune response without causing disease 
(Pijoan et al., 1997).   
 
Antimicrobials have been widely used in the swine industry to control bacterial 
respiratory diseases (Cromwell, 2002). About half of farms in the US with nursery-
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age pigs use injectable antimicrobials to treat respiratory diseases. The most common 
action for pigs with clinical respiratory disease is to administer antimicrobials to all 
pigs in the entire room, according to data from the National Animal Health 
Monitoring System Swine 2006 study (Anonymous, 2006). Antimicrobials exert a 
direct deleterious effect over bacterial infections by decreasing the bacterial load and 
permitting the host to activate immune defenses and eliminate the pathogen without 
excessive inflammation (Cromwell, 2002). Specifically for H. parasuis, 
antimicrobials are extremely useful in the control and treatment of Glasser’s disease 
(Aragon et al., 2012).   On the other hand, there are few reports indicating that 
antimicrobials can have unintended consequences by preventing the development of 
immunity, as described below. Antimicrobial treatment in the early stages of disease 
prevented the development of protective immunity against reinfection with Listeria 
sp. in mice, Chlamydia trachomatis in mice, Actinobacillus pleuropneumoniae in pigs 
and Salmonella typhimuium in mice (North et al., 1981; Su et al., 1999; Sjolund et al., 
2009; Griffin et al., 2009). In contrast, a recent study demonstrated that early 
antibiotic treatment with enrofloxacin against S. typhimurium infection in mice 
primed a specific antibody response, which protected against secondary challenge 
(Johanns et al, 2011). Antimicrobial treatment can also affect H. parasuis colonization 
(chapter 4, Vilalta et al., 2012). However, the effect of antimicrobials on the 
development of an effective immune response against H. parasuis requires further 
investigation.  
 
To better study the relationship between H. parasuis infection, immunity, protection 
and use of antibiotics, we used an animal model where conventional pigs were 
inoculated with a low dose of a pathogenic H. parasuis strain at weaning and were 
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treated with enrofloxacin, followed by homologous challenge. To our knowledge, 
there is no information available on how antimicrobials affect protection against H. 
parasuis in pigs experimentally colonized with a pathogenic H. parasuis strain. Our 
hypothesis is that enrofloxacin treatment will affect H. parasuis infection and 
subsequent development of a protective immune response against H. parasuis.  
 
Material and Methods 
Experimental design 
Sixty 3-week-old conventional pigs from seven different litters were selected from a 
specific pathogen free herd without history of Glasser’s disease. Pigs were 
individually identified, assigned to 6 groups of 10 pigs each, and equally distributed 
as far as possible in terms of sex, weight and litter of origin. Each group was kept in a 
separate isolation room and pigs were cared according to University of Minnesota 
approved Institutional Animal Care and Use Committee (IACUC) protocols.   
 
A summary of the experimental procedures for each group is shown in Figure 5.1 and 
Table 5.1. Three groups of pigs (EXP, EXP/ABT, ABT/EXP) were inoculated with a 
low dose of pathogenic H. parasuis (exposure) on day 0. Group ABT/EXP was also 
treated with enrofloxacin before inoculation on day -3 of the study. Group EXP/ABT 
was treated with enrofloxacin 3 days after inoculation. Group ABT was also treated 
with enrofloxacin on day 3 but was not exposed to low dose of pathogenic H. 
parasuis, and served as a control for the effect of the antibiotic treatment alone. Pigs 
in group CHA were only inoculated with a high dose of H. parasuis (challenge) on 
day 21 and served as positive controls. Groups EXP, EXP/ABT, ABT/EXP and ABT 
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were also challenged on day 21. Pigs in the negative control group (NEG) were 
untreated, non-exposed and non-challenged.  
 
At the termination of the study, at 25 or 35 DPI, pigs were euthanized and necropsied 
for pathological evaluation. Pigs showing severe clinical signs of disease including 
lethargy, respiratory distress, lameness or lateral recumbency were euthanized and 
necropsied as soon as severe clinical signs were identified. 
 
Haemophilus parasuis inoculation 
H. parasuis Nagasaki strain was selected for inoculation of piglets. This is a highly 
pathogenic reference strain extensively described in the literature (Cerda-Cuellar and 
Aragon, 2008; Aragon et al., 2009; Olvera et al., 2009; 2012; Frandoloso et al., 2012; 
2013). The Nagasaki strain had an in vivo passage using chicken eggs to increase its 
virulence (Oliveira and Pijoan (2002). Bacterial growth was harvested from chocolate 
agar plates, quantified, aliquoted and frozen at -80°C.  Prior to inoculation, cultures 
were diluted to produce an inoculum containing 106 (exposure at day 0) or 108 
(challenge at day 21) colony forming units (CFU)/ml of Nagasaki strain.  
 
Inoculation was performed as described in chapter 4. Pigs inoculated at the beginning 
of the study received 1.0 mL of inoculum containing 106 CFU/ml of Nagasaki strain 
intranasally (0.5 mL in each nostril) at day 0. Non-inoculated pigs received 1.0 mL of 
sterile saline intranasally. Before inoculation, pigs were sedated by an intramuscular 
injection in the cervical muscles of a dissociative anesthetic at recommended dose of 
6.6 mg/kg (0.06 ml/kg) (Telazol®, Fort Dodge Animal Health, Fort Dodge, IA). Once 
sedation was achieved (1-2 minutes), pigs were held upright and the inoculum was 
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instilled slowly into each nostril using a 1 mL syringe. Inoculation with high 
challenge dose was similarly performed on day 21 of the study, using an inoculum 
containing 108 CFU/mL of Nagasaki strain. 
 
Antimicrobial treatment 
Pigs treated with antimicrobial received a single dose of injectable enrofloxacin (7.5 
mg/kg of body weight, Baytril, Bayer Animal Health, Shawnee, Kansas, USA), 
subcutaneously, either 3 days prior (ABT/EXP) or post (EXP/ABT) low dose  
inoculation (Table 5.1). Pigs not treated received 1 mL of saline solution. 
Pigs that had clinical signs of Glasser’s disease, including body temperature above 
40° C, lethargy, respiratory distress, lameness or lateral recumbency were treated 
therapeutically with enrofloxacin following manufacturer specifications as described 
above.  
   
Sample collection 
Nasal swabs for bacterial isolation were collected at -3, 2, 7 and 17 DPI from all pigs 
in all groups and at  3 and  5 DPI from pigs in groups EXP, EXP/ABT and ABT/EXP. 
Laryngeal swabs were collected from groups EXP, EXP/ABT and ABT/EXP only at 
2, 3, 6, 7 and 18 DPI.  Swabs of nasal cavity, trachea, brain, pleura, pericardium, 
peritoneum and joints were collected at necropsy for H. parasuis isolation. H. 
parasuis isolation was also attempted from lung and liver tissues. Blood samples were 
collected at 2 and 23 DPI from exposed pigs to monitor for bacteremia through 
bacterial isolation and PCR (Oliveira et al., 2001b). Serum samples were collected at -
3, 17, 25 and 35 DPI for serological testing. Blood samples were also collected in 
EDTA tubes (BD VacutainerTM Glass Blood Collection tubes with K3 EDTA; 
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Franklin Lakes, NJ, USA) on days 0, 7, 15, 25 and 35 to evaluate the number of 
peripheral blood mononuclear cells (PBMCs) producing IFN-γ upon H. parasuis 
stimulation by Enzyme-Linked ImmunoSpot (ELISPOT).   
 
Clinico-pathological evaluation 
Body temperature and clinical signs compatible with Glässer’s disease (cough, 
lethargy, abdominal breath, lameness and lateral recumbency) were recorded daily 
after H. parasuis inoculation on day 0. Pigs showing signs of advanced Glasser’s 
disease were euthanized by a pentobarbital overdose (100 mg/kg, Fatal-Plus 
Solution®, Vortech Pharmaceuticals, Dearborn, MI, USA). At the termination of the 
study, at 25 or 35 DPI, pigs were euthanized and necropsied for evaluation of gross 
and microscopic lesions.  Lesions of pulmonary consolidation, presence of fibrin in 
abdomen, thorax and joints were recorded. Mortality associated to H. parasuis was 
confirmed by bacterial isolation from the lesions followed by genotyping by 
enterobacterial repetitive intergenic consensus (ERIC-PCR). 
 
H. parasuis isolation and characterization 
For isolation of H. parasuis, samples were plated onto sheep blood agar streaked with 
a nurse Staphylococcus aureus strain, and incubated at 37°C in a 5% carbon dioxide 
(CO2) atmosphere for 24 to 48 hours. Suspect colonies showing satellitism to the S. 
aureus nurse streak were isolated onto a new blood agar plate, incubated in similar 
conditions for 24 additional hours, and characterized through biochemical testing 
(Oliveira et al., 2003).  
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H. parasuis isolates were genotyped by ERIC-PCR (Rafiee et al., 2000) in order to 
distinguish between the Nagasaki strain and naturally colonizing commensal H. 
parasuis. Additionally, a multiplex PCR based on detection of the gene encoding 
virulence factor vtaA was used to differentiate non-pathogenic from potentially 
pathogenic H. parasuis isolates (Olvera et al, 2011).  
 
Detection of H. parasuis-specific IgG and IgA by ELISA 
To study antibody responses to H. parasuis, H. parasuis recombinant oligopeptide 
permease A (rOppA) protein was obtained as described previously (chapter 2) from 
GenScript Corp., Piscataway, New Jersey. The OppA protein is highly immunogenic, 
species-specific, conserved among H. parasuis strains, and is recognized by serum 
from pigs systemically infected with a wide variety of H. parasuis strains and 
serotypes (chapter 2).  
 
An in house ELISA to detect antibodies against the OppA was developed as described 
in chapter 2. Briefly, high binding plates were coated with 100 nanograms/well of 
recombinant OppA (Genscript) and blocked with 5% skim milk. Sera were diluted 
1:50 for IgG and IgA detection. Bronquioalveolar lavage fluid (BALF) was diluted 
1:8. Rabbit anti-porcine IgG HRP (Sigma-Aldrich, St. Louis, MO, USA) was diluted 
1:50000 and goat anti-porcine IgA HRP (Bethyl Laboratories, Montgomery, TX, 
USA) was diluted 1:3200. Antibodies were detected with peroxidase substrate (KPL, 
Gaithersburg, MD, USA). The plates were read at 450 nm using a microplate reader 
(ThermoMax Molecular Devices, Sunnyvale, CA).  
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Isolation, freezing and thawing of porcine PBMCs 
Peripheral blood mononuclear cells (PBMCs) were isolated by density gradient 
centrifugation of blood diluted 1:2 with sterile phosphate buffered saline (PBS) (Cell 
Signaling Technology, Danvers, MA, USA) on lymphocyte separation medium 
(Mediatech, Manassas, VA, USA). PBMCs were washed with PBS, and freed of red 
blood cells by ammonium-chloride-potassium (ACK) lysis buffer (Lonza, Alpharetta, 
GA, USA). Cells were resuspended in RPMI complete medium containing 1mM 
sodium pyruvate (Life Technologies, Grand Island, NY, USA), penicillin (100 U) and 
streptomycin (100 µg/mL) (Sigma-Aldrich, St. Louis, MO, USA). Cell viability was 
confirmed by trypan blue exclusion, and cells were counted using the Cellometer® 
Auto Counter T4 (Nexcelom Bioscience LLC, Lawrence, MA, USA). Cells were 
resuspended to 107 cell/mL with freezing solution containing 70% FBS, 20% cRPMI, 
10% Dimethyl Sulfoxide (Sigma-Aldrich, St. Louis, MO, USA) and kept on liquid 
nitrogen until use. Cells were thawed in 37°C water bath and washed with RPMI 
containing 5% FBS and 50 U/mL of benzonase nuclease (Sigma-Aldrich, St. Louis, 
MO, USA). Cells were resuspended with 1 mL of RPMI containing 10% FBS, 1mM 
sodium pyruvate (Life Technologies, Grand Island, NY, USA), penicillin (100 U) and 
streptomycin (100 µg/mL) (Sigma-Aldrich, St. Louis, MO, USA) and added to plates 
at specified concentration. 
 
ELISPOT assay for IFN-γ response 
As a measure of cell-mediated immune response to H. parasuis, IFN-γ production 
responses were assessed by in vitro stimulation of PBMCs with H. parasuis outer 
membrane proteins (OMPs) and mitogens for 24 hours, followed by measuring 
antigen-specific, actively secreting IFN-γ producing cells. 
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The method used for detergent-insoluble OMP extraction from H. parasuis has been 
described by Ruiz et al. (2001). Briefly, an overnight culture of H. parasuis Nagasaki 
strain in PPLO medium supplemented with 5% horse serum and 40 µg of NAD/mL 
was centrifuged for 10 minutes at 5,000 x g. The pellet was resuspended in 10 mM 
HEPES buffer (pH 7.4), and the suspension was subjected to sonication for 2 minutes 
at 22 µm amplitude (sonicator) in ice. Sonication was repeated until solution changed 
color from cloudy, turbid to translucent. Cellular debris was removed by 
centrifugation at 20,000 x g for 3 minutes at 4°C. The supernatant was then removed 
and centrifuged at 20,000 x g for 40 minutes at 4°C. The pellet containing the cell 
membrane material was resuspended in HEPES buffer and sodium lauryl sarcosinate 
(Sigma-Aldrich, St. Louis, MO, USA) (2% in HEPES buffer) for 30 minutes with 
intermittent mixing. After that, each preparation was centrifuged at 20,000 x g for 40 
minutes at 4°C. The membrane pellet was then resuspended in HEPES buffer to a 
concentration of 100 µg/mL and stored at -80°C.  
 
Microtiter PVDF plates (Millipore MultiScreenTM, EMD Millipore Corporation, 
Billerica, MA, USA) were coated with 100 µL/well of 1:60 dilution of anti-porcine 
IFN-γ  capture antibody (R&D Systems, Inc., Minneapolis, MN, USA) in PBS 
overnight at 4°C and blocked by adding 200 µL/well of  1% bovine serum albumin 
(BSA) in PBS. Cells were diluted in RPMI 1640 to a density of 500,000 cells per well 
in a volume of 50 µL/well. H. parasuis OMPs recall antigen (25 µg/well), 10 µg/mL 
of Concanavalin A (ConA) (positive control) (Sigma-Aldrich, St. Louis, MO, USA) 
or 25 µg/well of Hemocyanin from Megathura crenulata (keyhole limpet) KLH 
(Sigma-Aldrich, St. Louis, MO, USA) (negative control) was added to each well. 
Plates were incubated for 24 hours at 36°C in a CO2 incubator. Medium was removed, 
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and plates were washed six times with phosphate buffered saline with Tween-20 
(PBST) (Cell Signaling Technology, Danvers, MA, USA). One hundred mL/well of a 
1:100 dilution of anti-porcine IFN-γ detection antibody (R&D Systems, Inc., 
Minneapolis, MN, USA) were added in PBS with 1% BSA and incubated for 2 hours 
at room temperature (RT). Plates were washed again six times with PBST, and 100 
µL of 1:100 dilution of streptavidin-alkaline phosphatase in 1% BSA was added for 2 
hours at RT. After 4 washes, 100 µL/well of BCIP/NBT chromogen (R&D Systems, 
Inc., Minneapolis, MN, USA) was added and incubated in the dark for 30 minutes at 
RT, then rinsed with water and let dry at RT. Spots were quantified automatically by 
using a specialized automated ELISPOT reader (ImmunoSpot® 5.1 software, C.T.L. 
Analyzers, LLC, Cleveland, OH, USA). Data are presented as the mean numbers of 
H. parasuis-specific IFN-γ producing cells per 106 PBMCs from duplicate wells of 
each sample minus the number of cells on wells simulated by KLH. 
 
Statistical analysis 
The presence of clinical signs and lesions at necropsy were analyzed for significant 
differences between groups using Fisher’s exact test (p<0.05). Serology and 
ELISPOT data were statistically analyzed for differences between groups using 
Kruskal-Wallis test followed by Mann-Whitney pairwise comparison (p<0.05). 
Serology and ELISPOT data were also compared within groups by repeated measures 
Friedman’s ANOVA test, followed with multiple pairwise comparisons performed 
using Wilcoxon signed rank test (p<05). Survival analysis was used to compare the 
time of Nagasaki isolation from URT and the onset of clinical signs after H. parasuis 
inoculation. Differences between groups were analyzed by Cox Regression (P<0.05). 
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Results 
Clinico-pathological outcomes to H. parasuis inoculation 
After low dose inoculation, clinical signs were observed in 6/10 pigs from the EXP 
group and 5/10 pigs from the ABT/EXP group. These proportions of pigs with clinical 
signs were not statistically different from each other (Table 5.2), but were different 
from the EXP/ABT and the non-exposed groups (ABT, CHA and NEG) (p<0.05). 
Pigs in the other four groups did not show clinical signs.   
 
Four pigs from the EXP group had fever above 40°C at 4 DPI. Two of the affected 
pigs were euthanized and the other two were treated therapeutically with enrofloxacin 
as previously described. At 8 DPI, two other pigs from the EXP group presented fever 
and were immediately treated therapeutically (Table 5.2). The body temperatures of 
the therapeutically treated pigs returned to normal after 24 hours and they were kept 
in the study.  
 
Four pigs from the ABT/EXP group had temperature above 40°C after low dose 
inoculation, starting at 7 DPI. These pigs were similarly treated with enrofloxacin and 
their body temperature normalized 24 hours post treatment. However, one of the 
therapeutically treated pigs was found dead at 16 DPI. In addition, another pig from 
the same group was found in distress (lethargy and hypothermia) and was therefore 
euthanized at 7 DPI (Table 5.2). Although onset of clinical signs was observed sooner 
in group EXP (4- 8 days) compared to group ABT/EXP (7-8 days) (Table 5.2), no 
significant differences in the onset of clinical signs were found by Cox regression. 
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Necropsy of the two pigs from group EXP euthanized at 4 DPI revealed moderate 
arthritis in the hock joints of both posterior legs in pigs. The pig from group 
ABT/EXP euthanized on day 7 had mild peritonitis while the pig found dead on day 
16 did not have any lesions at necropsy. Nevertheless, H. parasuis was isolated from 
systemic sites from all necropsied pigs and confirmed as Nagasaki strain according to 
the ERIC-PCR pattern. 
 
Results on clinical outcomes after high dose challenge inoculation can be seen in 
Table 5.3. Pigs from the NEG, EXP and ABT/EXP groups did not show any signs of 
disease. In contrast, 4 out of 10 pigs in the EXP/ABT and CHA groups and 8 out 10 
pigs in the ABT group had clinical signs of disease after challenge, including fever, 
lethargy, coughing, respiratory distress, lameness and lateral recumbency. The 
proportion of affected pigs in groups EXP/ABT, ABT and CHA was statistically 
higher when compared to non-affected pigs (EXP, ABT/EXP and NEG groups) 
(p<0.05) (Table 5.3). Five pigs (4 from ATB and 1 from CHA groups) were 
euthanized before the first endpoint of the study (day 25 DPI) due to severe clinical 
signs (Table 5.3). At first necropsy day (25 DPI or earlier), 14 pigs (6 ABT, 4 CHA 
and 4 EXP/ABT) had lesions characteristic of Glasser’s disease, including 
fibrinopurulent pericarditis, pleuritis, peritonitis, arthritis, and pneumonia. Nagasaki 
strain was recovered from all 14 pigs from trachea, lung, liver or serosal sites (Table 
5.4 and Table 5.5). In addition, Nagasaki strain was recovered from the nose of only 
four affected pigs (1 EXP/ABT, 2 ABT and 2 CHA) (Table 5.4 and Table 5.5).  
 
Nasal, tracheal and serosal swabs collected at necropsy from the pigs from groups that 
did not show disease (NEG, EXP, ABT/EXP) tested negative for the Nagasaki strain. 
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Pigs that were not euthanized on 25 DPI remained healthy until day 35 DPI, and no 
lesion was observed during the second necropsy on 35 DPI. The only Nagasaki isolate 
recovered on 35 DPI was from the nose of two pigs from CHA group. 
 
H. parasuis isolation from the URT  
H. parasuis was isolated from nasal and laryngeal swabs of 54/60 pigs (90%) yielding 
142 isolates before challenge. Of those, 34 isolates were identified by ERIC-PCR as 
the pathogenic H. parasuis Nagasaki strain, which had been inoculated into the pigs. 
Overall, there were 28 Nagasaki H. parasuis isolates recovered from nasal swabs and 
6 from laryngeal swabs. The other 108 isolates were identified as a different strain 
that all pigs carried in the nasal cavity, and is referred to as “farm strain” hereafter. 
Nagasaki strain was differentiated from the farm strain by its unique ERIC-PCR 
fingerprint (chapter 2). Additionally, the Nagasaki strain was positive for the virulent 
vtaA gene (chapter 2), while the farm strain was not.  
 
The Nagasaki strain was cultured from nasal or laryngeal swabs from 8/10 pigs in 
group EXP, 9/10 pigs in group ABT/EXP and 5/10 pigs in group EXP/ABT before 
challenge. These differences in the proportion of pigs with positive URT cultures 
were not significantly different (Table 5.6). The time of first isolation ranged from 2 
to 7 DPI for pigs in group EXP, 2 to 7 in group ABT/EXP and 2 to 3 in group 
EXP/ABT. Although there was a delay in pigs yielding Nagasaki isolates in 
ABT/EXP group compared to EXP and EXP/ABT groups (Table 5.6), there were no 
significant differences in time to Nagasaki isolation by Cox regression (p>0.05). 
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The farm strain was isolated from 48/60 (80%) pigs, resulting in 108 isolates 
recovered before challenge (Table 5.7). The rate of isolation of the H. parasuis farm 
strain at the beginning of the study (-3 DPI) ranged between 40% and 80% in the 
different experimental groups (Table 5.7). These differences were not significantly 
different. The H. parasuis farm strain continued to be isolated throughout the study 
from the URT of pigs that were not treated with antibiotics (EXP, NEG and CHA). In 
contrast, H. parasuis farm strain was not isolated from pigs in groups EXP/ABT, 
ABT/EXP and ABT after enrofloxacin administration.  
 
Serological immune response 
To test whether inoculation with a low dose of pathogenic H. parasuis induced IgG 
and IgA antibodies against H. parasuis immunogen OppA, serum samples were 
analyzed by an in house H. parasuis ELISA. After low dose inoculation, serum IgG 
antibodies increased in pigs from groups EXP (average  OD of 1.13) and ABT/EXP 
(average OD of 0.99) on day 17 compared with day -3 (average OD of 0.17 and 0.18, 
respectively) (p<0.05) (Figure 5.2). Additionally, levels of serum IgG antibodies were 
higher for groups EXP and EXP/ATB on day 17, when compared to group EXP/ABT 
and non-inoculated groups (p<0.05). No significant increases in serum IgG antibodies 
were observed among the pigs from EXP/ABT group and control groups before 
challenge.  
 
Levels of serum IgA antibodies were significantly higher on day 17 for all groups, 
compared to day -3 DPI (p<0.05). A significant difference on IgA levels in serum was 
not observed between groups on day 0 or day 17 (p>0.05) (Figure 5.3).  
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After challenge (25 and 35 DPI), levels of serum IgG remained high for groups EXP 
and ABT/EXP (Figure 5.2). The levels of serum IgG antibodies significantly 
increased in pigs from groups EXP/ABT, ABT and CHA 14 days after challenge (35 
DPI) when compared to 25 DPI (p<0.05). Levels of serum IgG remained low in the 
NEG group throughout the study and significantly lower than the other groups on 35 
DPI (Figure 5.2).  Levels of serum IgA were statistically higher for all groups 
compared to NEG group on 35 DPI (p<0.05) (Figure 5.3).  
 
There were no differences between groups on IgG or IGA levels in BALF on day 25 
DPI. Levels of IgG in BALF were statistically higher in pigs from all challenged 
groups on day 35 when compared to NEG group (p<0.05) (Figure 5.4). However, no 
significant differences were observed among groups on the levels of IgA antibodies in 
BALF at 35 DPI (Figure 5.5).  
 
IFN-γ immune response  
The H. parasuis-specific cell-mediated immune response was assessed using an 
enzyme-linked immunosorbent spot assay (ELISPOT) designed to detect IFN-γ 
producing PBMCs. No differences on the number of IFN-γ producing cells were 
observed between groups on day -3. Pigs in EXP and ABT/EXP groups showed a 
statistically higher number of H. parasuis-specific IFN-γ producing cells at 7 and 15 
DPI, respectively, compared to day -3 (p<0.05) (Figures 5.6). In addition, on day 7, 
EXP group had significantly higher IFN-γ response compared to NEG group, while 
ABT/EXP group had a higher IFN-γ on day 15 DPI, when compared to other groups 
(P<0.05). A significant IFN- γ response was not observed in EXP/ABT and non-
exposed groups (ABT, CHA and NEG) after low dose inoculation. 
110 
 
 
After challenge, on 25 DPI, levels of H. parasuis-specific IFN-γ producing cells were 
statistically higher for all groups when compared with NEG group (p<0.05), (Figure 
5.6). By 35 DPI, no differences on IFN- γ responses were observed between groups. 
 
Discussion 
There is limited information on how antimicrobials modify the susceptibility of pigs 
to H. parasuis infection. In this study, we evaluated the use of enrofloxacin in relation 
to the timing of H. parasuis infection and the predisposition to Glasser’s disease. Our 
results indicated that enrofloxacin given 3 days after pigs were exposed controlled 
infection before pigs were able to activate a protective immune response. In contrast, 
enrofloxacin given 3 days before inoculation did not interfere with the development of 
an immune response, resulting in pigs being protected against challenge.  
 
Inoculation of pigs with a low dose of pathogenic H. parasuis resulted in most pigs 
being colonized by the pathogenic strain and having an increase on levels of IgG 
antibodies in serum. In addition, all pigs from EXP group were protected against 
challenge. Protection against Glasser’s disease after exposure to low dose of 
pathogenic H. parasuis is, to some extent, discordant in the literature. A different 
study reported that exposure to H. parasuis pathogenic strain at a young age resulted 
in protection from clinical disease in a farm setting (Oliveira et al., 2004). In contrast, 
when pigs were inoculated with a low dose of pathogenic H. parasuis in another 
study, only partial protection (3 out of 5 pigs) was reported after challenge with a high 
dose of the same strain (Martin de la Fuente et al., 2009a). Whether a subclinical or 
systemic infection by H. parasuis is needed to activate a protective immune response 
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or whether only colonization by a pathogenic H. parasuis strain would be enough to 
prime the immune system still needs further investigation. 
 
The protection observed by a low dose inoculation with H. parasuis was not affected 
by enrofloxacin given 3 days before Nagasaki inoculation. Similar to EXP group, 
most pigs from ABT/EXP group were colonized with the pathogenic strain and had 
increased levels of serum IgG antibodies.  Enrofloxacin is a fluoroquinolone that acts 
by inhibiting DNA gyrase, an enzyme responsible for bacterial replication, which 
leads to cell death. Enrofloxacin concentration peaks in plasma and nasal secretions of 
pigs between 1 and 2 hours after administration with terminal half-life of about 9 and 
12 hours in plasma and nasal secretions respectively (Bimazubute et al., 2009). Even 
though the duration of effective concentration of enrofloxacin in plasma and nasal 
secretions of swine is not known, data from this study suggests that the concentration 
of enrofloxacin 3 days after administration must have been low enough to allow the 
establishment of H. parasuis infection in pigs.  
 
On the contrary, enrofloxacin given 3 days after inoculation with the pathogenic strain 
interfered with protection against challenge. Neither the farm nor the Nagasaki H. 
parasuis strains were isolated from the URT of EXP/ABT group after enrofloxacin 
treatment. In addition, these pigs did not develop disease after colonization and an 
increase of IgG antibodies was not observed at 17 DPI. Finally, 40% of those pigs 
were susceptible to challenge on 21 DPI. Based on lack of H. parasuis isolation after 
enrofloxacin treatment, it appears that the antibiotic quickly prevented the immune 
response by inactivating and removing H. parasuis. In fact, besides its broad 
distribution on plasma and tissues, enrofloxacin also actively accumulates in 
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phagocytes and quickly eliminates susceptible bacteria by enhancing intraphagocytic 
killing (Schoevers et al., 1999). Alternatively, the enrofloxacin treatment may have 
had a direct immunosuppressant effect on the immune system of injected pigs. 
Fluoroquinolones are known to have modulating effects on the immune response, by 
decreasing the synthesis of pro-inflammatory cytokines, such as IL-1 and TNF (Khan 
et al., 2000), which could have contributed to the absence of immune response in 
group EXP/ABT.  More research is needed, however, to investigate whether such 
immunomodulatory effects would affect the immune response to H. parasuis. 
 
Groups EXP and ABT/EXP had significantly higher levels of IgG antibodies in serum 
at 17 DPI and were protected against challenge at 21 DPI. The groups that were 
seronegative at 17 DPI (EXP/ABT, ABT and CHA), showed an increase of IgG 
antibodies in serum at 31 DPI. In addition, all challenged groups had higher levels of 
IgG antibodies in serum and BALF than non-challenged NEG group (p<0.05). 
Therefore, pigs systemically infected by a pathogenic H. parasuis strain develop 
serum IgG antibodies, which are the main immune correlate of protection from 
Glasser’s disease in this study. This finding is in agreement with several previous 
reports (Solano-Aguilar et al., 1999; Martin de la Fuente et al., 2009; Nedbalcova et 
al., 2011). 
 
On the other hand, an increase on serum IgA was observed for all groups at 17 DPI 
compared to day -3. The cause of this increase in IgA remains unknown. No 
differences were observed between groups until 35 DPI, when all challenged groups 
had higher levels of serum IgA compared to the NEG group. In BALF, no differences 
on IgA levels were observed between groups on 25 and 35 DPI. In other studies, pigs 
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vaccinated with a killed H. parasuis vaccine were protected against challenge, and 
serum IgG immunity developed without a robust serum IgA antibody response 
(Olvera et al., 2013; Martinez-Martinez et al., 2013). Apparently, serum IgA response 
is activated after H. parasuis systemic infection or vaccination, but does not seem to 
play a significant role on protection against disease. 
 
Moreover, an average increase of IFN-γ producing cells was observed on EXP group 
at 7 DPI when compared to NEG group, and on ABT/EXP group at 15 DPI when 
compared to all the other groups (Figure 5.6). The higher levels of IFN-γ producing-
cells are apparently associated with onset of clinical signs in those two groups. In a 
different study, an increase of IFN-γ concentrations was also described in the sera of 
piglets after vaccination (Hu et al., 2013). In the present study, no increase of IFN-γ 
producing cells was observed in EXP/ABT after low dose inoculation, probably 
because the infection was eliminated before an immune response could be developed. 
Furthermore, quinolones antimicrobials have been shown to decrease IFN-γ 
expression in human T lymphocytes under in vitro conditions (William et al., 2005), 
with potential implications for immune response and recovery after severe infection, 
but the mechanisms of such effects need further investigation in vivo. After challenge, 
all groups had a significantly higher IFN-γ response at 25 DPI when compared to 
NEG group. The number of IFN-γ producing cells was not different from background 
on day 35, apparently because IFN-γ response seems to be transient in blood and it is 
dissipated after peak of infection from days 22 to 25 (1 to 4 days after challenge).  
 
In summary, in this study we demonstrated that antibiotic treatment can alter the 
development of a protective immune response for H. parasuis and that this effect is 
114 
 
dependent on the timing of antibiotic administration relative to infection. In addition, 
it is possible to speculate on the relative role of the different immune responses in the 
observed protection against H. parasuis challenge: serum IgA and IFN-γ producing-
cells did not appear to play a significant role. In contrast, serum IgG levels were 
associated with protection. Protection against re-infection is highly desirable in 
commercial herds, where repeated exposures to H. parasuis are common. Controlling 
disease with potent antimicrobials such as enrofloxacin before pigs had time to 
develop a protective immune response might result in clinical disease if pigs become 
reinfected. On the other hand, treating pigs when clinical signs of disease are evident 
does not seem to interfere with protection against re-infection because the immune 
response may already have been activated. Overall more work on understanding the 
immune response against H. parasuis infection is needed to understand the protective 
immune mechanisms against H. parasuis infection. In addition, studies including 
different antimicrobials would provide valuable information to better assess 
appropriate timing and judicious use of antimicrobial treatment in pigs.  
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Table 5.1. Experimental design summary. 
  Days of the study 
Groups 
Number 
of pigsa -3 0 3 21 25/35 
EXP 10  Exposurec  Challenged Necropsy 
ABT/EXP 10 Enrofloxacinb Exposure  Challenge Necropsy 
EXP/ABT 10  Exposure Enrofloxacin Challenge Necropsy 
ABT 10   Enrofloxacin Challenge Necropsy 
CHA 10    Challenge Necropsy 
NEG 10     Necropsy 
a 3-week-old, high-health pigs 
b One dose of 7.5 mg/kg injectable enrofloxacin (Baytril® 100)  
c Inoculation with H. parasuis Nagasaki strain at a low dose of 106 CFU/ml 
d Inoculation with H. parasuis Nagasaki strain at a high dose of 108 CFU/ml 
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Table 5.2. Clinical outcome after low dose Haemophilus parasuis Nagasaki strain 
inoculation. 
Group 
Number of 
inoculated pigs 
Number of clinically 
afftected pigs1 
Days from inoculation 
to clinical signs 
EXP 10 6a 4,4,4,4,8,8 
ABT/EXP 10 5 a 7,7,8,8,8 
EXP/ABT 10 0 b - 
ABT 0 0 b - 
CHA 0 0 b - 
NEG 0 0 b - 
 a Clinical signs included fever > 40°C, prostration, swollen joints, respiratory distress, 
and lateral recumbency. 
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Table 5.3. Proportion of pigs positive for Haemophilus parasuis Nagasaki strain 
isolation after challenge (23 to 35 DPI). 
Group Nose Trachea Lung Serosa 
EXP 0/8 0/8a 0/8 0/8 a 
ABT/EXP 0/8 0/8a 0/8 0/8 a 
EXP/ABT 1/10 4/10b 0/10 2/10 a 
ABT 2/10 5/10b 5/10 5/10 b 
CHA 2/10 6/10b 3/10 2/10 a 
NEG 0/10 0/10 a 0/10 0/10 a 
Different letters indicate significant differences between groups (p<0.05). 
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Table 5.4. Clinical outcome after challenge by inoculation with a high dose of 
Haemophilus parasuis Nagasaki strain. 
Group 
Number of clinically 
afftected pigs1 
Days from challenge 
to clinical signs 
Presence of lesions at 
necropsy 
EXP 0/8a - 0/8 a 
ABT/EXP 0/8a - 0/8 a 
EXP/ABT 4/10a 3,3,3,3 4/10 b 
ABT 8/10b 2,2,3,3,3,3,3,4 6/10 b 
CHA 4/10a 2,2,3,3, 4/10 b 
NEG 0/10a - 0/10 a 
1Clinical signs included fever > 40°C, prostration, swollen joints, respiratory distress, 
and lateral recumbency. 
Different letters indicate significant differences between groups (p<0.05). 
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Table 5.5. Isolation of Haemophilus parasuis Nagasaki strain from pigs with lesions 
at necropsy (23 to 35 DPI).* 
   Necropsy specimens† 
Groups 
Pig 
no. 
Days post-
challenge 
Ns Tr Pl Lu Pc Lv Pt Jt 
EXP/ABT 57 4 - + + - + - - - 
23 4 + + - - - - - - 
56 4 - + + - - - - - 
9 4 - + - - - - - - 
ABT 19 2 + + + + + + + - 
37 2 - + + + + + + - 
40 3 + + + + - + + + 
32 3 - - + - + + + + 
5 4 - + + + + - - - 
54 4 - + - + - - - - 
CHA 39 3 + + + + + + + - 
11 4 + + - + + + - - 
59 4 - + - + - - - - 
24 4 - + - - - - - - 
*(+) = Isolation of Nagasaki strain; (-) = Negative culture for Nagasaki strain 
†Ns: nasal swab, Tr: traqueal swab, Pl: pleural swab, Lu: lung, Pc: pericardial swab, 
Lv: liver, Pt: peritoneal swab, Jt: joint swab. 
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Table 5.6. Number of pigs with positive cultures for Haemophilus parasuis Nagasaki 
strain from nasal or laryngeal swabs after inoculation with a low dose. 
 Days of the study  
Groups -3 2 3 5 7 18 Total6 
EXP1 0/10 5/10 2/10 1/84 3/8 0/8 8/10a 
ABT2/EXP 0/10 1/10 1/10 4/10 8/10 0/85 9/10 a 
EXP/ABT3 0/10 2/10 5/10 0/10 0/10 0/10 5/10 a 
ABT 0/10 0/10 0/10 0/10 0/10 0/10 0/10 b 
CHA 0/10 0/10 0/10 0/10 0/10 0/10 0/10 b 
NEG 0/10 0/10 0/10 0/10 0/10 0/10 0/10 b 
1 Low dose inoculation on day 0.  
2 Enrofloxacin treatment was given on day -3. 
3 Enrofloxacin treatment was given on day 3. 
4 Two pigs were euthanized on day 4 of the study. 
5 Two pigs were euthanized on day 7 and 16 of the study. 
6Total number of pigs with at least one positive culture for Nagasaki strain. 
Different letters indicate significant differences between groups (p<0.05). 
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Table 5.7. Number of pigs with positive cultures for Haemophilus parasuis farm 
strain from nasal and laryngeal swabs.  
 Days of the study  
Groups -3 2 3 5 7 18 Totale 
EXPa 8/10 3/10 3/10 4/8 1/8 3/8 10/10 
ABT/EXPb 5/10 0/10 0/10 0/10 0/9 0/8 5/10 
EXP/ABTc 6/10 6/10 1/10 0/10 0/10 0/10 10/10 
ABTb 4/10 5/10 NSd NS 0/10 0/10 5/10 
CHA 4/10 3/10 NS NS 6/10 5/10 9/10 
NEG 5/10 6/10 NS NS 3/10 6/10 9/10 
a Low dose inoculation took place on day 0. 
b Enrofloxacin treatment was given on day -3.  
c Enrofloxacin treatment was given on day 3. 
d Not sampled. 
e Total number of pigs tested positive for the Nagasaki isolate. 
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Figure 5.1. Experimental design timeline. 
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Figure 5.2. Average levels of serum IgG antibodies optical density (OD) prior to start 
the study (day -3), prior to challenge (day 17) and at necropsy (days 25 or 35). 
Different letters indicate significant differences between groups (p<0.05). 
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Figure 5.3. Average levels of IgA antibodies optical density (OD) in serum prior to 
start the study (day -3), prior to challenge (day 17) and at necropsy (days 25 or 35).  
 Different letters indicate significant differences between groups (p<0.05). 
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Figure 5.4. Average levels of IgG antibodies optical density (OD) against 
Haemophilus parasuis in BALF at necropsy (days 25 or 35). Different letters indicate 
significant differences between groups (p<0.05). 
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Figure 5.5. Average levels of IgA antibodies optical density (OD) against 
Haemophilus parasuis in BALF at necropsy (days 25 or 35). Different letters indicate 
significant differences between groups (p<0.05). 
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Figure 5.6. Average number of Haemophilus parasuis-specific interferon gamma 
(IFN-γ) spot forming units (SFU) per 106 cells by day Different letters indicate 
significant differences between groups (p<0.05). 
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CHAPTER 6 
GENERAL DISCUSSION AND CONCLUSION 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
129 
 
 
Glasser’s disease is an important source of economic losses in commercial swine 
production systems. The success of controlled exposure in the field suggests that early 
exposure (colonization) with pathogenic H. parasuis protects pigs from Glasser’s 
disease (Oliveira et al., 2004a). However, little is known about the immune response 
that is generated during colonization rather than during systemic infection. 
Understanding H. parasuis colonization and the associated immune response will 
contribute to the development of better control programs.   
 
There is also a need to understand the factors that can modulate the immune response 
to H. parasuis, such as the use of antibiotic treatments. Over the past few years, use of 
antimicrobials has become more common in young pigs. Increase of H. parasuis 
disease has been observed in selected herds with an increase in use of antibiotics. It is 
possible that alteration of colonization patterns of H. parasuis at a young age has 
resulted in an increase in H. parasuis problems as the pigs get older. While the use of 
antibiotic medication helps pigs recover from H. parasuis infection, it may also affect 
H. parasuis colonization and alter the development of an effective immune response. 
Therefore, the effect of antibiotics on the development of an effective immune 
response requires further investigation. Towards this end, the goal of this PhD 
dissertation was to investigate the influence of antimicrobial treatment on H. parasuis 
colonization and infection, and its effect on the development of immune responses 
against H. parasuis in swine. 
 
To investigate the serological immune response against H. parasuis, an ELISA assay 
was developed. The ELISA assay was based on a newly identified H. parasuis 
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antigen (chapter 2). The immunogenic and species-specific H. parasuis protein was 
detected by screening H. parasuis whole cell proteins using swine convalescent sera. 
This protein was identified as an oligopeptide permease A (OppA). This ELISA test 
proved to be valuable to detect specific antibodies against H. parasuis in infected or 
vaccinated animals.  Therefore, the OppA ELISA provides a method for surveillance 
of H. parasuis infections. This test was useful for the subsequent chapters of this 
thesis and should be an important new tool for the study of H. parasuis pathogenesis 
and immune response in both experimental and field studies.     
 
The immunogenicity of OppA was evidenced by the fact that only convalescent pigs 
or pigs vaccinated with recombinant OppA (rOppA) developed antibodies against it. 
Healthy pigs colonized by H. parasuis did not possess antibodies against OppA. The 
specificity of OppA was evidenced by absence of anti-OppA antibodies in colostrum-
deprived pigs, SPF pigs and pigs infected with A. pleuropneumoniae or other common 
swine bacterial species. The robust antibody response to rOppA protein after 
vaccination further showed that OppA is highly immunogenic in swine. However, 
OppA protein seroconversion did not translate to protection against H. parasuis 
infection.  
 
A major limitation of chapter 2 is that few serum samples of a limited number of 
farms were used to validate the OppA ELISA test. Future studies should use 
additional samples especially from pigs known to be free of H. parasuis and pigs 
experimentally inoculated with different H. parasuis strains. Evaluation of OppA 
ELISA under field conditions is also important. Specifically, the evaluation of 
antibody responses to OppA on farms with and without episodes of Glasser’s disease 
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and, whether the OppA ELISA is a reliable tool to monitor the transfer of maternal 
immunity against H. parasuis to piglets need further investigation.    
 
In chapter 3, the goal was to develop an experimental model of pathogenic H. 
parasuis that mimics asymptomatic colonization in conventional pigs. Such a model 
was necessary to study factors that affect colonization of H. parasuis in conventional 
pigs. In our model, pigs were experimentally inoculated with pathogenic H. parasuis 
and we showed that all pigs carried pathogenic H. parasuis on their URT mucosa for 
up to seven days post inoculation without developing Glasser’s disease. Absence of 
disease was evidenced by lack of clinical signs and lesions, and lack of H. parasuis 
isolation and H. parasuis DNA detection in blood and systemic tissues. The 
colonization model developed as part of this thesis provides a new tool to study the 
pathogenesis and immune response to H. parasuis in conventional pigs.  
 
While swine are the ideal model to study H. parasuis pathogenesis, there are negative 
aspects to using conventional swine. In general, pigs are naturally colonized with H. 
parasuis strains shortly after birth. The pigs used in this study were known to be H. 
parasuis positive and carried a genetically distinct strain of H. parasuis as part of the 
URT commensal bacteria. Although the commensal H. parasuis strain was identified 
and differentiated from the inoculated strain Nagasaki, it is possible that interactions 
between the 2 strains may exist. We did not account for possible interactions in this 
study as only pigs from a single source were used. Furthermore, we could not 
differentiate whether some of the responses observed were due to the presence of 
commensal strains, the pathogenic strain or the interaction among them. The H. 
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parasuis strain naturally established on the nasal mucosa is a complicating factor for 
the reproducibility of this model and further validation is needed.  
 
In chapter 4, we evaluated the effect of the antimicrobial enrofloxacin on the 
colonization of H. parasuis in conventional pigs. We did this to evaluate whether 
enrofloxacin had an effect on H. parasuis found in the URT. We documented the 
reduction of the number of pigs testing positive to H. parasuis and the reduction of 
levels of H. parasuis in tonsils and nasal cavity of conventional pigs during the first 
week after enrofloxacin treatment. However, results also showed that enrofloxacin at 
the approved dose did not eliminate H. parasuis from nose and tonsils of the pigs. In 
this study, we could not differentiate between complete elimination and re-exposure 
from environmental sources, or presence of low grade persistence and recrudescence 
after the antibiotic effect was gone. This study was important to show that 
colonization of H. parasuis in healthy pigs can be altered by antimicrobial treatment 
and further supported the general hypothesis of this thesis. Prior to initiate this study, 
a minimum number of piglets was chosen based on estimated standard deviations and 
means, since a power analysis was not feasible. There was no preliminary data 
available to educate sample size selection, yet significant differences in number of 
pigs colonized by H. parasuis were detected. 
 
The study in chapter 4 did not address whether the reduction on H. parasuis load by 
enrofloxacin can compromise the ability of pigs to develop an immune response when 
pigs are infected with a pathogenic H. parasuis strain.  The study in chapter 5 was 
conducted to determine the effect of enrofloxacin on the development of immune 
responses to H. parasuis and its impact on protection from challenge. The inoculation 
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of pigs with a low dose of pathogenic H. parasuis protected pigs against challenge. In 
addition, we showed that timing of enrofloxacin administration in relation to H. 
parasuis exposure was important to develop protection to a subsequent H. parasuis 
challenge. The protection observed after H. parasuis inoculation was not affected by 
enrofloxacin given 3 days before inoculation. In contrast, enrofloxacin given 3 days 
after inoculation with H. parasuis interfered with protection against challenge. Based 
on the lack of H. parasuis isolation after enrofloxacin treatment, it appeared that the 
antibiotic quickly inactivated and removed H. parasuis. Alternatively, 
fluoroquinolones are known to have modulating effects on the immune response, by 
decreasing the synthesis of pro-inflammatory cytokines, such as IL-1 and TNF (Khan 
et al., 2000), which could have contributed to the absence of immune response.  More 
research is needed, however, to investigate how enrofloxacin would affect the 
immune response to H. parasuis. 
 
The serological assay used to measure IgG antibodies in this study was the OppA 
ELISA described in chapter 2. In chapter 5, we showed that pigs protected against 
challenge had an increase of OppA antibodies in serum after inoculation with a low 
dose of H. parasuis. In this study, anti-OppA antibodies were the main immune 
correlate of protection from Glasser’s disease. In contrast, no differences were 
observed on levels of serum IgA antibodies and levels of IgG and IgA in BALF 
between inoculated groups. The IFN-γ response appeared to be associated with the 
onset of clinical disease after H. parasuis inoculation, but a clear association of IFN-γ 
response to protection was not evident. Therefore, more research is needed to evaluate 
the role of IFN-γ responses on protection against H. parasuis infection. 
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Results from chapter 5 also suggest that the use of potent antimicrobials, such as 
enrofloxacin, to control bacterial disease before pigs have time to activate a protective 
immune response may result in clinical disease when pigs become reinfected. On the 
other hand, treating pigs when clinical signs of disease are evident does not seem to 
interfere with protection against re-infection because the immune response may 
already have been activated. Overall more work to understand the immune response 
against H. parasuis infection is needed to evaluate the protective immune mechanisms 
against H. parasuis infection.  
 
Taken together, the information generated in this thesis provides essential information 
on proper timing of antimicrobial treatment in the face of H. parasuis infection and 
immune response development. Data presented here showed that, for the given 
infectious dose of pathogenic H. parasuis used, more than 3 days of live bacteria 
exposure is necessary for pigs to seroconvert and be protected against reinfection. 
Enrofloxacin-induced abridgement of infection on day 3 post inoculation resulted in 
the absence of serum IgG response and protection.  
 
The conclusions drawn from the data presented in chapter 5 may not be extendable to 
other pathogens or antimicrobials. Future studies should focus on investigating 
whether these conditions would change based on dose of H. parasuis inoculum, time 
of antimicrobial treatment and H. parasuis strains used. A complementary line of 
research would focus on the field application of the concepts presented in this thesis. 
Clinical trials can be developed that use the data provided in this thesis to compare 
different protocols of enrofloxacin administration in the face of a Glasser’s disease 
outbreak.  
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Moreover, new efforts to understand the mucosal immune response to H. parasuis are 
needed, since serum IgA results in this study were inconclusive. The fact that secreted 
antibodies in the URT were not measured in piglets is a limitation since the pigs were 
naturally colonized. Future studies need to differentiate immune responses to the 
naturally colonizing farm strains from the immune responses to the inoculated strains 
to clarify how the pig’s immune system responds to H. parasuis.   
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